Curable resin composition and display device
The curable resin composition with quantum dots, carboxyl/thiol compounds, and photopolymerization initiator addresses low dispersibility and slow development in conventional compositions, achieving faster and brighter cured films.
Patent Information
- Application Number
- CN202180025408.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2020-03-31
- Filing Date
- 2021-03-19
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2041-03-19
AI Technical Summary
Conventional curable resin compositions containing quantum dots suffer from low dispersibility, leading to reduced luminous intensity and prolonged development times, necessitating improvements in dispersibility and development speed.
A curable resin composition comprising quantum dots, a compound with carboxyl or thiol functional groups, a resin, a photopolymerizable compound, and a photopolymerization initiator, which enhances dispersibility and development speed, resulting in a cured film with improved luminous intensity.
The composition achieves high dispersibility of quantum dots, leading to faster development and increased luminous intensity in the cured film, while also improving solvent resistance and residual film rate.
Smart Images

Figure BDA0003868844530000021 
Figure BDA0003868844530000051 
Figure BDA0003868844530000071
Abstract
Description
Technical Field
[0001] The present invention relates to a curable resin composition, a cured film thereof, and a display device including the cured film. Background Art
[0002] Patent Document 1 describes a curable resin composition containing quantum dots and a wavelength conversion film formed using the curable resin composition.
[0003] Prior art literature
[0004] Patent Literature
[0005] Patent Document 1: Japanese Patent Application Publication No. 2016-065178 Summary of the invention
[0006] Conventional curable resin compositions containing quantum dots as wavelength conversion materials (luminescent materials) have room for improvement in the dispersibility of the quantum dots in the composition. When the dispersibility of the quantum dots is low, the luminous intensity (brightness) of the wavelength-converted light emitted from the quantum dots in the cured film formed by the curable resin composition is easily reduced.
[0007] Furthermore, the development speed of conventional curable resin compositions may be relatively long, and there is still room for improvement.
[0008] An object of the present invention is to provide a curable resin composition which has a sufficiently high development speed and can form a cured film having a good luminous intensity.
[0009] Another object of the present invention is to provide a cured film formed from the curable resin composition, and a display device including the cured film.
[0010] The present invention provides the curable resin composition, cured film, and display device shown below.
[0011] [1] A curable resin composition comprising quantum dots (A), a compound (B-1) having a first functional group and a second functional group, a resin (C), a photopolymerizable compound (D) and a photopolymerization initiator (E),
[0012] The first functional group is a carboxyl group, and the second functional group is a carboxyl group or a thiol group.
[0013] [2] The curable resin composition according to [1], wherein the molecular weight of the compound (B-1) is 3,000 or less.
[0014] [3] The curable resin composition according to [1] or [2], further comprising a compound (B-2) which is different from the compound (B-1), comprises a polyalkylene glycol structure and has a polar group at a molecular terminal.
[0015] [4] The curable resin composition according to [3], wherein the content of the compound (B-2) is 1 to 50 in mass ratio relative to the content of the compound (B-1).
[0016] [5] The curable resin composition according to any one of [1] to [4], wherein the resin (C) is a polyalkylene glycol compound.
[0017] [6] The curable resin composition according to any one of [1] to [5], wherein the content of the photopolymerizable compound (D) is 13% by mass or more relative to the total amount of solid content of the curable resin composition.
[0018] [7] The curable resin composition according to any one of [1] to [6], wherein the photopolymerizable compound (D) contains 50% by mass or more of a photopolymerizable compound having three or more ethylenically unsaturated bonds in a molecule and having no carboxyl group.
[0019] [8] The curable resin composition according to any one of [1] to [7], wherein the photopolymerization initiator (E) comprises an oxime compound having a first molecular structure represented by the following formula (1).
[0020]
[0021] [In formula (1), R 1 Represents R 11 , OR 11 , COR 11 , SR 11 ,CONR 12 R 13 or CN,
[0022] R 11 , R 12 and R 13 each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an aralkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms,
[0023] R 11 , R 12 or R 13 The hydrogen atoms of the group represented by OR 21 , COR 21 , SR21 NR 22 Ra 23 ,CONR 22 R 23 , -NR 22 -OR 23 , -N(COR 22 )-OCOR 23 、-C(=N-OR 21 )-R 22 、-C(=N-OCOR 21 )-R 22 , CN, halogen atoms, or COOR 21 replace,
[0024] R 21 , R 22 and R 23 each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an aralkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms,
[0025] R 21 , R 22 or R 23 The hydrogen atoms of the groups represented by may be substituted by CN, halogen atoms, hydroxyl groups, or carboxyl groups.
[0026] R 11 , R 12 , R 13 , R 21 , R 22 or R 23 When the group represented by has an alkylene moiety, the alkylene moiety may be represented by -O-, -S-, -COO-, -OCO-, -NR 24 -, -NR 24 CO-、-NR 24 COO-、-OCONR 24 -, -SCO-, -COS-, -OCS- or -CSO- interrupted 1 to 5 times,
[0027] R 24 represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an aralkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms,
[0028] R 11 , R 12 , R 13 , R 21 , R 22 or R 23When the group represented by has an alkyl portion, the alkyl portion may be branched or cyclic. 12 With R 13 and R 22 With R 23 can form a ring together,
[0029] * represents a bonding site with another molecular structure other than the first molecular structure of the oxime compound, that is, the second molecular structure.]
[0030] [9] A cured film formed from the curable resin composition according to any one of [1] to [8].
[0031]
[10] A display device comprising the cured film described in [9].
[0032] The present invention can provide a curable resin composition having a sufficiently high development speed and capable of forming a cured film having good luminescence intensity, a cured film formed from the curable resin composition, and a display device including the cured film. DETAILED DESCRIPTION
[0033] <Curable resin composition>
[0034] The curable resin composition of the present invention (hereinafter, also simply referred to as “curable resin composition”) contains quantum dots (A), a compound (B-1), a resin (C), a photopolymerizable compound (D), and a photopolymerization initiator (E).
[0035] [1]Quantum dot(A)
[0036] Quantum dots (A) are semiconductor particles with a particle size of 1 nm to 100 nm, which absorb ultraviolet light or visible light using the band gap of the semiconductor to emit light.
[0037] Examples of the quantum dot (A) include CdS, CdSe, CdTe, ZnS, ZnSe, ZnTe, HgS, HgSe, HgTe, CdHgTe, CdSeS, CdSeTe, CdSTe, ZnSeS, ZnSeTe, ZnSTe, HgSeS, HgSeTe, HgSTe, C dZnS, CdZnSe, CdZnTe, CdHgS, CdHgSe, CdHgTe, HgZnS, HgZnSe, HgZnTe, CdZnSeS, CdZnSeTe, CdZnSTe, CdHgSeS, CdHgSeTe, CdHgSTe, HgZnSeS, Hg Compounds of Group IIB elements such as ZnSeTe, HgZnSTe and Group VIA elements; compounds of Group IIIA elements such as GaN, GaP, GaAs, AlN, AlP, AlAs, InN, InP, InAs, GaNP, GaNAs, GaPAs, AlNP, AlNAs, AlPAs, InNP, InNAs, InPAs, GaAlNP, GaAlNAs, GaAlPAs, GaInNP, GaInNAs, GaInPAs, InAlNP, InAlNAs, InAlPAs and Group VA elements; compounds of Group IVA elements such as PdS, PbSe and Group VIA elements, etc.
[0038] When the quantum dots (A) contain S and Se, those surface-modified with metal oxides or organic substances may be used. By using surface-modified quantum dots, it is possible to prevent S and Se from being taken away by reactive components contained or may be contained in the curable resin composition.
[0039] Furthermore, the quantum dots (A) may be formed into a core-shell structure by combining the above compounds. Examples of such a combination include fine particles having a CdSe core and a ZnS shell, and fine particles having an InP core and a ZnSeS shell.
[0040] The energy state of quantum dots (A) depends on their size, so the emission wavelength can be freely selected by changing the particle size. For example, in the case of quantum dots composed only of CdSe, the peak wavelengths of the fluorescence spectrum when the particle size is 2.3nm, 3.0nm, 3.8nm, and 4.6nm are 528nm, 570nm, 592nm, and 637nm, respectively.
[0041] In addition, the spectral width of the light emitted from the quantum dots (A) is narrow, and by combining light having such a steep peak, the color gamut that can be displayed can be expanded in a display device including a cured film formed from a curable resin composition. Furthermore, the quantum dots (A) have high responsiveness and can efficiently utilize the light emitted from the light source.
[0042] The curable resin composition may contain only one quantum dot that emits light of a specific wavelength according to the light radiated from the light source, or may contain a combination of two or more quantum dots that emit light of different wavelengths. Examples of the light of the specific wavelength include red light, green light, and blue light.
[0043] The content of the quantum dots (A) in the curable resin composition is, for example, 1% to 60% by mass, preferably 10% to 50% by mass, more preferably 15% to 50% by mass, further preferably 20% to 50% by mass, and further preferably 20% to 40% by mass, relative to the total amount of solid components of the curable resin composition.
[0044] The total amount of solid content in the present specification refers to the total amount of components contained in the curable resin composition excluding the solvent (G). The content of the solid content in the curable resin composition can be measured by a known analytical means such as liquid chromatography or gas chromatography.
[0045] [2] Compound (B-1)
[0046] Compound (B-1) is a compound having a first functional group and a second functional group. The first functional group is a carboxyl group (-COOH), and the second functional group is a carboxyl group or a thiol group (-SH). Since compound (B-1) has a carboxyl group and / or a thiol group, it can be a ligand coordinated to quantum dot (A).
[0047] The curable resin composition may contain only one type of compound (B-1), or may contain two or more types.
[0048] By making the curable resin composition contain compound (B-1), the development speed of the curable resin composition can be made sufficiently fast, and the luminous intensity (brightness) of the cured film formed by the curable resin composition can be improved. This is believed to be because the carboxyl group and thiol group possessed by compound (B-1) can both give the curable resin composition high developability based on alkaline developer, and can be fully coordinated to the quantum dots (A) to improve the dispersibility of the quantum dots (A) in the curable resin composition. In particular, the carboxyl group has a higher effect on improving the developability based on alkaline developer, and the thiol group has a higher effect on improving the dispersibility of the quantum dots (A).
[0049] Increasing the development speed of the curable resin composition also contributes to improving the luminous intensity (brightness) of the cured film. This is considered to be because it is possible to suppress the penetration of water into the cured film during the development step.
[0050] Moreover, by making a curable resin composition contain a compound (B-1), the solvent resistance of a cured film can be improved, and thereby the residual film rate measured in the Example column mentioned later can be improved.
[0051] An example of the compound (B-1) is a compound represented by the following formula (B-1a). The compound (B-1) may be an acid anhydride of the compound represented by the formula (B-1a).
[0052]
[0053] [Where R B Represents a divalent hydrocarbon group. B When there are multiple substituents, they may be the same or different. The above hydrocarbon group may have one or more substituents. When there are multiple substituents, they may be the same or different, and they may be bonded to each other and form a ring together with the atoms to which they are bonded. The -CH2- contained in the above hydrocarbon group may be substituted with at least one of -O-, -S-, -SO2-, -CO- and -NH-.
[0054] p represents an integer from 1 to 10.]
[0055] As R B Examples of the divalent hydrocarbon group represented by include a chain hydrocarbon group, an alicyclic hydrocarbon group, and an aromatic hydrocarbon group.
[0056] Examples of the chain hydrocarbon group include a linear or branched alkanediyl group, and the number of carbon atoms of the chain hydrocarbon group is usually 1 to 50, preferably 1 to 20, and more preferably 1 to 10.
[0057] Examples of the linear or branched alkanediyl group include propane-1,2-diyl, propane-1,3-diyl, butane-1,4-diyl, pentane-1,5-diyl, hexane-1,6-diyl, heptane-1,7-diyl, octane-1,8-diyl, nonane-1,9-diyl, decane-1,10-diyl, undecane-1,11-diyl, dodecane-1,12-diyl, propane-1,2-diyl, 1-methylbutane-1,3-diyl, 2-methylpropane-1,3-diyl, pentane-1,4-diyl, and 2-methylbutane-1,4-diyl.
[0058] Examples of the alicyclic hydrocarbon group include monocyclic and polycyclic cycloalkanediyl groups, and the alicyclic hydrocarbon group has usually 3 to 50 carbon atoms, preferably 3 to 20 carbon atoms, and more preferably 3 to 10 carbon atoms.
[0059] Examples of the monocyclic or polycyclic cycloalkanediyl group include cyclobutane-1,3-diyl, cyclopentane-1,3-diyl, cyclohexane-1,4-diyl, norbornane-1,4-diyl, norbornane-2,3-diyl, norbornane-2,5-diyl, 5-norbornene-2,3-diyl, adamantane-1,5-diyl, and adamantane-2,6-diyl.
[0060] Examples of the aromatic hydrocarbon group include arene diyl groups, and the number of carbon atoms thereof is usually 6 to 20. Examples of the monocyclic or polycyclic arene diyl groups include benzene diyl, naphthalene diyl, anthracene diyl, phenanthrene diyl, pyrene diyl, pyridine diyl, pyrazine diyl, and pyrazole diyl.
[0061] Examples of the substituent which the hydrocarbon group may have include an alkyl group having 1 to 50 carbon atoms, a cycloalkyl group having 3 to 50 carbon atoms, an aryl group having 6 to 20 carbon atoms, a carboxyl group, an amino group, and a halogen atom.
[0062] Examples of the alkyl group having 1 to 50 carbon atoms include saturated or unsaturated linear or branched alkyl groups, and specifically include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, neopentyl, and 2-ethylhexyl.
[0063] Examples of the cycloalkyl group having 3 to 50 carbon atoms include cyclopropyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl.
[0064] Examples of the aryl group having 6 to 20 carbon atoms include phenyl, biphenyl, tolyl, xylyl, ethylphenyl and naphthyl.
[0065] Examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
[0066] The substituent that the above hydrocarbon group may have is preferably a carboxyl group, an amino group or a halogen atom.
[0067] When -CH2- contained in the above hydrocarbon group is substituted with at least one of -O-, -CO- and -NH-, the substitution for -CH2- is preferably at least one of -CO- and -NH-, more preferably -NH-.
[0068] p is preferably 1 or 2.
[0069] Examples of the compound represented by formula (B-1a) include compounds represented by the following formulae (1-1) to (1-9).
[0070]
[0071] If specific examples of the compound represented by formula (B-1a) are represented by chemical names, for example, mercaptoacetic acid, 2-mercaptopropionic acid, 3-mercaptopropionic acid, 3-mercaptobutyric acid, 4-mercaptobutyric acid, mercaptosuccinic acid, mercaptostearic acid, mercaptooctanoic acid, 4-mercaptobenzoic acid, 2,3,5,6-tetrafluoro-4-mercaptobenzoic acid, L-cysteine, N-acetyl-L-cysteine, 3-methoxybutyl 3-mercaptopropionate, 3-mercapto-2-methylpropionic acid, etc. can be mentioned.
[0072] Among them, 3-mercaptopropionic acid and mercaptosuccinic acid are preferred.
[0073] Another example of the compound (B-1) is a polycarboxylic acid compound, and preferably, a compound (B-1b) in which -SH in the formula (B-1a) is substituted with a carboxyl group (-COOH) among the compounds represented by the above formula (B-1a).
[0074] Examples of the compound (B-1b) include the following compounds.
[0075] Succinic acid, glutaric acid, adipic acid, octafluoroadipic acid, azelaic acid, dodecanedioic acid, tetradecanedioic acid, hexadecanedioic acid, heptadecanedioic acid, octadecanedioic acid, nonadecanedioic acid, dodecafluorooctanedioic acid, 3-ethyl-3-methylglutaric acid, hexafluoroglutaric acid, trans-3-hexenedioic acid, sebacic acid, hexadecanoic acid, acetylenedicarboxylic acid, trans-aconitic acid, 1,3-adamantanedicarboxylic acid, bicyclo[2.2.2]octane-1,4-dicarboxylic acid, cis-4-cyclohexene-1,2-dicarboxylic acid, 1,1-cyclopropanedicarboxylic acid, 1,1-cyclobutanedicarboxylic acid, cis- or trans-1,3-cyclohexanedicarboxylic acid, cis- or trans-1 ,4-cyclohexanedicarboxylic acid, 1,1-cyclopentanediacetic acid, 1,2,3,4-cyclopentanetetracarboxylic acid, decahydro-1,4-naphthalene dicarboxylic acid, 2,3-norbornene dicarboxylic acid, 5-norbornene-2,3-dicarboxylic acid, phthalic acid, 3-fluorophthalic acid, isophthalic acid, tetrafluoroisophthalic acid, terephthalic acid, tetrafluoroterephthalic acid, 2,5-dimethylterephthalic acid, 2,6-naphthalene dicarboxylic acid, 2,3-naphthalene dicarboxylic acid, 1,4-naphthalene dicarboxylic acid, 1,1'-ferrocene dicarboxylic acid, 2,2'-biphenyl dicarboxylic acid, 4,4'-biphenyl dicarboxylic acid, 2,5-furan dicarboxylic acid, benzophenone-2,4'-dicarboxylic acid Acid monohydrate, benzophenone-4,4'-dicarboxylic acid, 2,3-pyrazinedicarboxylic acid, 2,3-pyridinedicarboxylic acid, 2,4-pyridinedicarboxylic acid, 3,5-pyridinedicarboxylic acid, 2,5-pyridinedicarboxylic acid, 2,6-pyridinedicarboxylic acid, 3,4-pyridinedicarboxylic acid, pyrazole-3,5-dicarboxylic acid monohydrate, 4,4'-stilbenedicarboxylic acid, anthraquinone-2,3-dicarboxylic acid, 4-(carboxymethyl)benzoic acid, chelidonic acid monohydrate, azobenzene-4,4'-dicarboxylic acid, azobenzene-3,3'-dicarboxylic acid, chlorendic acid, 1H-imidazole-4,5-dicarboxylic acid, 2,2-bis(4-carboxyphenyl)hexafluoropropane, 1,10- Bis(4-carboxyphenoxy)decane, dipropylmalonic acid, dithiodiglycolic acid, 3,3'-dithiodipropionic acid, 4,4'-dithiodibutyric acid, 4,4'-dicarboxydiphenyl ether, 4,4'-dicarboxydiphenyl sulfone, ethylene glycol bis(4-carboxyphenyl) ether, 3,4-ethylenedioxythiophene-2,5-dicarboxylic acid, 4,4'-isopropylidene diphenoxyacetic acid, 1,3-acetone dicarboxylic acid, methylene disalicylic acid, 5,5'-thiodisalicylic acid, tris(2-carboxyethyl)isocyanurate, tetrafluorosuccinic acid, α,α,α',α'-tetramethyl-1,3-benzenedipropionic acid, 1,3,5-benzenetricarboxylic acid, etc.
[0076] From the viewpoint of increasing the development speed of the curable resin composition and improving the luminous intensity (brightness) of the cured film, the molecular weight of the compound (B-1) is preferably 3000 or less, more preferably 2000 or less, further preferably 1000 or less, further preferably 800 or less, and particularly preferably 500 or less. The molecular weight of the compound (B-1) is usually 100 or more.
[0077] The molecular weight may be a number average molecular weight or a weight average molecular weight. In this case, the number average molecular weight and the weight average molecular weight are respectively the number average molecular weight and the weight average molecular weight measured by gel permeation chromatography (GPC) in terms of standard polystyrene.
[0078] In the curable resin composition, it is preferred that at least a portion of the molecules of the compound (B-1) are coordinated to the quantum dot (A), and it is also possible that all or substantially all of the molecules are coordinated to the quantum dot (A). That is, the curable resin composition preferably contains the compound (B-1) coordinated to the quantum dot (A), and it may contain the compound (B-1) not coordinated to the quantum dot (A) together with the compound (B-1) coordinated to the quantum dot (A).
[0079] From the perspective of increasing the development speed of the curable resin composition and improving the luminescence intensity (brightness) of the cured film, it is advantageous to include a compound (B-1) coordinated to the quantum dot (A). The compound (B-1) can usually be coordinated to the quantum dot (A) via the first functional group and / or the second functional group. For example, the compound (B-1) can be coordinated to the surface of the quantum dot (A).
[0080] The content ratio of the compound (B-1) to the quantum dot (A) in the curable resin composition is preferably 0.001 to 1, more preferably 0.01 to 0.5, and further preferably 0.02 to 0.1 in terms of mass ratio. When the content ratio is within this range, it is advantageous from the viewpoint of increasing the developing speed of the curable resin composition and improving the luminous intensity (brightness) of the cured film.
[0081] From the viewpoint of increasing the development speed of the curable resin composition and improving the luminous intensity (brightness) of the cured film, the content of the compound (B-1) in the curable resin composition is preferably 0.1% by mass to 20% by mass, more preferably 0.1% by mass to 10% by mass, further preferably 0.2% by mass to 8% by mass, further preferably 0.2% by mass to 5% by mass, and particularly preferably 0.5% by mass to 4% by mass, relative to the total amount of the solid content of the curable resin composition.
[0082] [3] Compound (B-2)
[0083] The curable resin composition may contain a compound (B-2) in addition to the compound (B-1). The compound (B-2) is a compound (B-2) different from the compound (B-1), and is a compound containing a polyalkylene glycol structure and having a polar group at the molecular end. The molecular end is preferably the end of the longest carbon chain (the carbon atoms in the carbon chain may be substituted by other atoms such as oxygen atoms) in the compound (B-2).
[0084] The curable resin composition may contain only one type of compound (B-2), or may contain two or more types.
[0085] In addition, the compound which contains a polyalkylene glycol structure and has the said 1st functional group and 2nd functional group belongs to compound (B-1).
[0086] From the viewpoint of increasing the development speed of the curable resin composition and improving the light emission intensity (brightness) of the cured film, the curable resin composition preferably further contains a compound (B-2).
[0087] The polyalkylene glycol structure refers to a structure represented by the following formula (n is an integer of 2 or more).
[0088]
[0089] In the formula, R C The alkylene group includes, for example, an ethylene group and a propylene group.
[0090] Specific examples of the compound (B-2) include polyalkylene glycol compounds represented by the following formula (B-2a).
[0091]
[0092] In formula (B-2a), X is a polar group, Y is a monovalent group, and Z is C is a divalent or trivalent group. n is an integer greater than 2. m is 1 or 2. C It is an alkylene group.
[0093] In the curable resin composition, it is preferred that at least a portion of the molecules of the compound (B-2) are coordinated to the quantum dot (A), and it is also possible that all or substantially all of the molecules are coordinated to the quantum dot (A). That is, the curable resin composition preferably contains the compound (B-2) coordinated to the quantum dot (A), and it may contain the compound (B-2) not coordinated to the quantum dot (A) together with the compound (B-2) coordinated to the quantum dot (A).
[0094] From the viewpoint of making the development speed of the curable resin composition faster and increasing the luminous intensity (brightness) of the cured film, it is advantageous to include a compound (B-2) coordinated to the quantum dot (A). Compound (B-2a) can usually be coordinated to the quantum dot (A) via the polar group X. When group Y contains a polar group, compound (B-2a) can also be coordinated to the quantum dot (A) via the polar group of group Y, or via the polar group X and the polar group of group Y. Compound (B-2) can be coordinated to the surface of quantum dot (A), for example.
[0095] The polar group X is preferably at least one group selected from the group consisting of a thiol group (-SH), a carboxyl group (-COOH) and an amino group (-NH2). The polar group selected from this group is advantageous in terms of improving the coordination to the quantum dot (A). Among them, from the viewpoint of improving the luminous intensity (brightness) of the cured film, the polar group X is more preferably at least one group selected from a thiol group and a carboxyl group.
[0096] The group Y is a monovalent group. The group Y is not particularly limited, and examples thereof include a monovalent hydrocarbon group which may have a substituent (N, O, S, a halogen atom, etc.). The -CH2- contained in the hydrocarbon group may be substituted by -O-, -S-, -C(=O)-, -C(=O)-O-, -O-C(=O)-, -C(=O)-NH-, -NH-, etc.
[0097] The number of carbon atoms in the hydrocarbon group is, for example, 1 to 12. The hydrocarbon group may have an unsaturated bond.
[0098] As the group Y, there can be mentioned an alkyl group having 1 to 12 carbon atoms and having a straight chain, branched chain or cyclic structure; an alkoxy group having 1 to 12 carbon atoms and having a straight chain, branched chain or cyclic structure. The number of carbon atoms of the alkyl group and the alkoxy group is preferably 1 to 8, more preferably 1 to 6, and further preferably 1 to 4. The -CH2- contained in the alkyl group and the alkoxy group may be substituted by -O-, -S-, -C(=O)-, -C(=O)-O-, -O-C(=O)-, -C(=O)-NH-, -NH-, etc. Among them, the group Y is preferably a straight chain or branched chain alkoxy group having 1 to 4 carbon atoms, and more preferably a straight chain alkoxy group having 1 to 4 carbon atoms.
[0099] The group Y may contain a polar group. As the polar group, at least one group selected from a thiol group (-SH), a carboxyl group (-COOH) and an amino group (-NH2) may be cited. Among them, as described above, a compound containing a polyalkylene glycol structure and having the above-mentioned first functional group and second functional group belongs to compound (B-1). The polar group is preferably arranged at the end of the group Y.
[0100] Group Z Cis a divalent or trivalent group. C There are no particular limitations, and examples thereof include divalent or trivalent hydrocarbon groups which may contain heteroatoms (N, O, S, halogen atoms, etc.). The number of carbon atoms in the hydrocarbon group is, for example, 1 to 24. The hydrocarbon group may have an unsaturated bond.
[0101] For the group Z as a divalent group C , examples include alkylene groups having 1 to 24 carbon atoms and having a linear, branched or cyclic structure; alkenylene groups having 1 to 24 carbon atoms and having a linear, branched or cyclic structure, etc. The number of carbon atoms in the alkyl and alkenylene groups is preferably 1 to 12, more preferably 1 to 8, and even more preferably 1 to 4. -CH2- contained in the alkyl and alkenylene groups may be substituted by -O-, -S-, -C(=O)-, -C(=O)-O-, -O-C(=O)-, -C(=O)-NH-, -NH-, etc. For the group Z as a trivalent group C Examples of the divalent group Z include C A group obtained by removing one hydrogen atom from a .
[0102] Group Z C It may have a branched structure. Group Z having a branched structure C A branch chain different from the branch chain including the polyalkylene glycol structure represented by the above formula (B-2a) may have a polyalkylene glycol structure different from the polyalkylene glycol structure represented by the above formula (B-2a).
[0103] Among them, group Z C It is preferably a linear or branched alkylene group having 1 to 6 carbon atoms, and more preferably a linear alkylene group having 1 to 4 carbon atoms.
[0104] R C It is an alkylene group, preferably a linear or branched alkylene group having 1 to 6 carbon atoms, and more preferably a linear alkylene group having 1 to 4 carbon atoms.
[0105] In the formula (B-2a), n is an integer of 2 or more, preferably 2-540, more preferably 2-120, and even more preferably 2-60.
[0106] The molecular weight of the compound (B-2) may be, for example, about 150 to 10,000, and is preferably 150 to 5,000, more preferably 150 to 4,000, from the viewpoint of increasing the development speed of the curable resin composition and improving the luminous intensity (brightness) of the cured film.
[0107] The molecular weight may be a number average molecular weight or a weight average molecular weight. In this case, the number average molecular weight and the weight average molecular weight are respectively the number average molecular weight and the weight average molecular weight in terms of standard polystyrene measured by GPC.
[0108] The content ratio of the compound (B-2) to the quantum dot (A) in the curable resin composition is preferably 0.001 to 2, more preferably 0.01 to 1.5, and even more preferably 0.1 to 1. When the content ratio is within this range, it is advantageous from the viewpoint of increasing the development speed of the curable resin composition and improving the luminous intensity (brightness) of the cured film.
[0109] The curable resin composition may further contain a compound (B-3) which is a compound other than the compound (B-1) and the compound (B-2) and has a coordination ability with respect to the quantum dot (A).
[0110] Examples of the compound (B-3) include organic acids, organic amine compounds, thiol compounds, etc. In the present specification, the compound (B-1), the compound (B-2), and the compound (B-3) may be collectively referred to as the compound (B).
[0111] The compound (B-3) does not contain the resin (C), the photopolymerizable compound (D), the photopolymerization initiator (E), the photopolymerization initiation aid (E1), the antioxidant (F), the solvent (G), the leveling agent (H) and the light scattering agent (I).
[0112] When the curable resin composition further contains compound (B-3), the ratio of the total content of compound (B-2) and compound (B-3) to the content of quantum dots (A) is preferably 0.001 to 2, more preferably 0.01 to 1.5, and even more preferably 0.1 to 1. When the content ratio is within this range, it is advantageous from the viewpoint of increasing the development speed of the curable resin composition and improving the luminous intensity (brightness) of the cured film.
[0113] The content ratio of the compound (B-2) to the compound (B-1) in the curable resin composition is preferably 1 to 50, more preferably 5 to 40, and even more preferably 10 to 25, in terms of mass ratio. When the content ratio is within this range, it is advantageous from the viewpoint of increasing the developing speed of the curable resin composition and from the viewpoint of improving the luminous intensity (brightness) of the cured film.
[0114] The molecular weight of compound (B-1) is preferably smaller than the molecular weight of compound (B-2). When the curable resin composition further contains compound (B-3), the molecular weight of compound (B-1) is preferably smaller than the molecular weight of at least one of compound (B-2) and compound (B-3). From the perspective of increasing the development speed of the curable resin composition and improving the luminous intensity (brightness) of the cured film, it is advantageous to satisfy such a molecular weight relationship.
[0115] From the viewpoint of increasing the development speed of the curable resin composition and improving the luminous intensity (brightness) of the cured film, the content of the compound (B-2) in the curable resin composition is preferably 0.1% by mass to 40% by mass, more preferably 0.1% by mass to 20% by mass, further preferably 1% by mass to 15% by mass, and further preferably 2% by mass to 10% by mass, relative to the total amount of the solid content of the curable resin composition.
[0116] [4] Resin (C)
[0117] Examples of the resin (C) include the following resins [K1] to [K4].
[0118] Resin [K1]: a copolymer of at least one (a) selected from unsaturated carboxylic acids and unsaturated carboxylic anhydrides (hereinafter also referred to as “(a)”) and a monomer (c) copolymerizable with (a) (which is different from (a)) (hereinafter also referred to as “(c)”);
[0119] Resin [K2]: a resin obtained by reacting a copolymer of (a) and (c) with a monomer (b) having a cyclic ether structure having 2 to 4 carbon atoms and an ethylenically unsaturated bond (hereinafter also referred to as "(b)");
[0120] Resin [K3]: a resin obtained by reacting a copolymer of (b) and (c) with (a);
[0121] Resin [K4]: A resin obtained by reacting a copolymer of (b) and (c) with (a), and further reacting with a carboxylic anhydride.
[0122] Examples of (a) include unsaturated monocarboxylic acids such as (meth)acrylic acid, crotonic acid, o-, m-, and p-vinylbenzoic acid;
[0123] Unsaturated dicarboxylic acids such as maleic acid, fumaric acid, citraconic acid, mesaconic acid, itaconic acid, 3-vinylphthalic acid, 4-vinylphthalic acid, 3,4,5,6-tetrahydrophthalic acid, 1,2,3,6-tetrahydrophthalic acid, dimethyltetrahydrophthalic acid, and 1,4-cyclohexenedicarboxylic acid;
[0124] Bicyclic unsaturated compounds containing a carboxyl group, such as methyl-5-norbornene-2,3-dicarboxylic acid, 5-carboxybicyclo[2.2.1]hept-2-ene, 5,6-dicarboxybicyclo[2.2.1]hept-2-ene, 5-carboxy-5-methylbicyclo[2.2.1]hept-2-ene, 5-carboxy-5-ethylbicyclo[2.2.1]hept-2-ene, 5-carboxy-6-methylbicyclo[2.2.1]hept-2-ene and 5-carboxy-6-ethylbicyclo[2.2.1]hept-2-ene;
[0125] Unsaturated dicarboxylic anhydrides such as maleic anhydride, citraconic anhydride, itaconic anhydride, 3-vinylphthalic anhydride, 4-vinylphthalic anhydride, 3,4,5,6-tetrahydrophthalic anhydride, 1,2,3,6-tetrahydrophthalic anhydride, dimethyltetrahydrophthalic anhydride, 5,6-dicarboxybicyclo[2.2.1]hept-2-ene anhydride;
[0126] Unsaturated mono-(meth)acryloyloxyalkyl) esters of divalent or higher polycarboxylic acids such as mono-(2-(meth)acryloyloxyethyl) succinate and mono-(2-(meth)acryloyloxyethyl) phthalate;
[0127] Unsaturated (meth)acrylates containing a hydroxyl group and a carboxyl group in the same molecule such as α-(hydroxymethyl) (meth)acrylic acid, and the like.
[0128] Among them, (meth)acrylic acid, maleic anhydride, and the like are preferred from the viewpoint of copolymerization reactivity and solubility of the obtained resin in an aqueous alkali solution.
[0129] In the present specification, (meth)acrylic acid means acrylic acid and / or methacrylic acid. The same applies to "(meth)acryloyl", "(meth)acrylate" and the like.
[0130] (b) is, for example, a monomer having a cyclic ether structure having 2 to 4 carbon atoms (for example, at least one selected from an oxirane ring, an oxetane ring, and a tetrahydrofuran ring) and an ethylenically unsaturated bond. (b) is preferably a monomer having a cyclic ether structure having 2 to 4 carbon atoms and a (meth)acryloyloxy group.
[0131] Examples of (b) include glycidyl (meth)acrylate, β-methyl glycidyl (meth)acrylate, β-ethyl glycidyl (meth)acrylate, glycidyl vinyl ether, o-vinylbenzyl glycidyl ether, m-vinylbenzyl glycidyl ether, p-vinylbenzyl glycidyl ether, α-methyl-o-vinylbenzyl glycidyl ether, α-methyl-m-vinylbenzyl glycidyl ether, α-methyl-p-vinylbenzyl glycidyl ether, 2,3-bis(glycidyloxymethyl)styrene, Monomers having an oxirane ring and an ethylenically unsaturated bond, such as 2,4-bis(glycidyloxymethyl)styrene, 2,5-bis(glycidyloxymethyl)styrene, 2,6-bis(glycidyloxymethyl)styrene, 2,3,4-tris(glycidyloxymethyl)styrene, 2,3,5-tris(glycidyloxymethyl)styrene, 2,3,6-tris(glycidyloxymethyl)styrene, 3,4,5-tris(glycidyloxymethyl)styrene, and 2,4,6-tris(glycidyloxymethyl)styrene;
[0132] Monomers having an oxetane ring and an ethylenically unsaturated bond, such as 3-methyl-3-methacryloyloxymethyloxetane, 3-methyl-3-acryloyloxymethyloxetane, 3-ethyl-3-methacryloyloxymethyloxetane, 3-ethyl-3-acryloyloxymethyloxetane, 3-methyl-3-methacryloyloxyethyloxetane, 3-methyl-3-acryloyloxyethyloxetane, 3-ethyl-3-methacryloyloxyethyloxetane, and 3-ethyl-3-acryloyloxyethyloxetane;
[0133] Monomers having a tetrahydrofuran ring and an ethylenically unsaturated bond, such as tetrahydrofurfuryl acrylate (for example, Viscoat V#150, manufactured by Osaka Organic Chemical Industry Co., Ltd.) and tetrahydrofurfuryl methacrylate, etc.
[0134] As (b), a monomer having an oxirane ring and an ethylenically unsaturated bond is preferred because the reactivity during the production of the resins [K2] to [K4] is high and unreacted (b) is less likely to remain.
[0135] Examples of (c) include methyl (meth)acrylate, ethyl (meth)acrylate, n-butyl (meth)acrylate, sec-butyl (meth)acrylate, tert-butyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, dodecyl (meth)acrylate, lauryl (meth)acrylate, stearyl (meth)acrylate, cyclopentyl (meth)acrylate, cyclohexyl (meth)acrylate, 2-methylcyclohexyl (meth)acrylate, tricyclo[5.2.1.0](meth)acrylate, 2,6] decane-8-yl ester (in the technical field, it is commonly known as "dicyclopentanyl (meth)acrylate". It is also sometimes referred to as "tricyclodecyl (meth)acrylate"), tricyclo[5.2.1.0 2,6 (Meth)acrylates such as decen-8-yl ester (in the technical field, it is commonly known as "dicyclopentenyl (meth)acrylate"), dicyclopentyloxyethyl (meth)acrylate, isobornyl (meth)acrylate, adamantyl (meth)acrylate, allyl (meth)acrylate, propargyl (meth)acrylate, phenyl (meth)acrylate, naphthyl (meth)acrylate, and benzyl (meth)acrylate;
[0136] (Meth)acrylates containing a hydroxyl group, such as 2-hydroxyethyl (meth)acrylate and 2-hydroxypropyl (meth)acrylate;
[0137] Diethyl maleate, diethyl fumarate, diethyl itaconate and other dicarboxylic acid diesters;
[0138] Bicyclo[2.2.1]hept-2-ene, 5-methylbicyclo[2.2.1]hept-2-ene, 5-ethylbicyclo[2.2.1]hept-2-ene, 5-hydroxybicyclo[2.2.1]hept-2-ene, 5-hydroxymethylbicyclo[2.2.1]hept-2-ene, 5-(2'-hydroxyethyl)bicyclo[2.2.1]hept-2-ene, 5-methoxybicyclo[2.2.1]hept-2-ene, 5-ethoxybicyclo[2.2.1]hept-2-ene, 5,6-dihydroxybicyclo[2.2.1]hept-2-ene, 5,6-bis(hydroxymethyl)bicyclo[2.2.1]hept-2-ene, 5,6-bis(2'-hydroxyethyl)bicyclo[2.2.1]hept-2-ene, 5,6-dimethoxy Bicyclic unsaturated compounds such as bicyclo[2.2.1]hept-2-ene, 5,6-diethoxybicyclo[2.2.1]hept-2-ene, 5-hydroxy-5-methylbicyclo[2.2.1]hept-2-ene, 5-hydroxy-5-ethylbicyclo[2.2.1]hept-2-ene, 5-hydroxymethyl-5-methylbicyclo[2.2.1]hept-2-ene, 5-tert-butoxycarbonylbicyclo[2.2.1]hept-2-ene, 5-cyclohexyloxycarbonylbicyclo[2.2.1]hept-2-ene, 5-phenoxycarbonylbicyclo[2.2.1]hept-2-ene, 5,6-bis(tert-butoxycarbonyl)bicyclo[2.2.1]hept-2-ene and 5,6-bis(cyclohexyloxycarbonyl)bicyclo[2.2.1]hept-2-ene;
[0139] Dicarbonyl imide derivatives such as N-phenylmaleimide, N-cyclohexylmaleimide, N-benzylmaleimide, N-succinimidyl-3-maleimidobenzoate, N-succinimidyl-4-maleimidobutyrate, N-succinimidyl-6-maleimidohexanoate, N-succinimidyl-3-maleimidopropionate, and N-(9-acridinyl)maleimide;
[0140] Styrene, α-methylstyrene, m-methylstyrene, p-methylstyrene, vinyltoluene, p-methoxystyrene, acrylonitrile, methacrylonitrile, vinyl chloride, vinylidene chloride, acrylamide, methacrylamide, vinyl acetate, 1,3-butadiene, isoprene, 2,3-dimethyl-1,3-butadiene, etc.
[0141] Among them, styrene, vinyltoluene, N-phenylmaleimide, N-cyclohexylmaleimide, N-benzylmaleimide, bicyclo[2.2.1]hept-2-ene and the like are preferred from the viewpoint of copolymerization reactivity and heat resistance of the resin (C).
[0142] In resin [K1], the ratio of the structural units derived from each monomer in all the structural units constituting resin [K1] is preferably 2 mol% to 60 mol% for the structural units derived from (a), and 40 mol% to 98 mol% for the structural units derived from (c), and more preferably 10 mol% to 50 mol% for the structural units derived from (a), and 50 mol% to 90 mol% for the structural units derived from (c).
[0143] When the ratio of the structural unit of the resin [K1] is within the above range, the storage stability of the curable resin composition, the developability of the curable resin composition, and the solvent resistance of the obtained cured pattern tend to be excellent.
[0144] In this specification, a cured pattern is one aspect of a cured film, and refers to a cured film formed in a pattern shape.
[0145] The resin [K1] can be produced, for example, by the method described in the document "Experimental Methods for Polymer Synthesis" (Otsu Takayuki Publishing Co., Ltd., Chemical Dojin, 1st edition, 1st printing, published on March 1, 1972) and the references described in the document.
[0146] Specifically, a method is exemplified in which predetermined amounts of (a) and (c), a polymerization initiator, a solvent, etc. are placed in a reaction vessel, oxygen is replaced with nitrogen to create a deoxygenated atmosphere, and heating and heat preservation are performed while stirring.
[0147] The polymerization initiator and solvent used here are not particularly limited, and polymerization initiators and solvents commonly used in this field can be used. For example, as polymerization initiators, azo compounds (2,2'-azobisisobutyronitrile, 2,2'-azobis(2,4-dimethylvaleronitrile) and organic peroxides (benzoyl peroxide and the like) can be mentioned, and as solvents, any solvent that dissolves each monomer can be mentioned, and the solvents described later as the solvent (G) that can be contained in the curable resin composition of the present invention can be mentioned.
[0148] The obtained copolymer may be used directly as a solution after the reaction, or as a solution after concentration or dilution, or as a solid (powder) obtained by reprecipitation or the like. If a solvent (G) described later is used as a solvent during polymerization, the solution after the reaction can be used directly to prepare a curable resin composition, thereby simplifying the manufacturing process of the curable resin composition.
[0149] The resin [K2] can be produced by adding a cyclic ether having 2 to 4 carbon atoms contained in (b) to the carboxylic acid and / or carboxylic anhydride contained in (a), to a copolymer of (a) and (c).
[0150] First, a copolymer of (a) and (c) is produced in the same manner as described as the method for producing resin [K1]. In this case, the ratio of the structural units derived from each monomer is preferably the same as the ratio described for resin [K1].
[0151] Next, a part of the carboxylic acid and / or carboxylic anhydride derived from (a) in the above copolymer is reacted with the cyclic ether having 2 to 4 carbon atoms contained in (b).
[0152] After the production of the copolymer of (a) and (c), the atmosphere in the flask is replaced from nitrogen to air, and the reaction is carried out in the presence of (b), a reaction catalyst (e.g., an organic phosphorus compound, a metal complex, an amine compound, etc.) of a carboxylic acid or a carboxylic anhydride and a cyclic ether, and a polymerization inhibitor (e.g., hydroquinone, etc.), for example, at 60° C. to 130° C. for 1 to 10 hours, thereby producing resin [K2].
[0153] The amount of (b) used is preferably 5 to 80 mol, more preferably 10 to 75 mol, relative to 100 mol of (a). Within this range, there is a tendency for the storage stability of the curable resin composition, the developability of the curable resin composition, and the solvent resistance, heat resistance, mechanical strength and sensitivity of the obtained cured pattern to be well balanced.
[0154] For example, triphenylphosphine can be used as an organic phosphorus compound as a reaction catalyst. For example, aliphatic tertiary amine compounds and aliphatic quaternary ammonium salt compounds can be used as amine compounds as a reaction catalyst. As specific examples thereof, for example, tris(dimethylaminomethyl)phenol, triethylamine, tetrabutylammonium bromide, tetrabutylammonium chloride, etc. can be used. From the viewpoint of the developability of the curable resin composition and the luminous intensity of the cured film, the reaction catalyst is preferably an organic phosphorus compound.
[0155] The amount of the reaction catalyst used is preferably 0.001 to 5 parts by mass based on 100 parts by mass of the total amount of (a), (b), and (c).
[0156] The amount of the polymerization inhibitor used is preferably 0.001 to 5 parts by mass based on 100 parts by mass of the total amount of (a), (b), and (c).
[0157] The reaction conditions such as the charging method, reaction temperature and time can be appropriately adjusted in consideration of the production equipment, the calorific value based on the polymerization, etc. It should be noted that the charging method and reaction temperature can be appropriately adjusted in consideration of the production equipment, the calorific value based on the polymerization, etc., similarly to the polymerization conditions.
[0158] As for resin [K3], as the first stage, a copolymer of (b) and (c) is obtained in the same manner as in the production method of the above-mentioned resin [K1]. As in the above, the obtained copolymer may be used directly as a solution after the reaction, or may be used as a concentrated or diluted solution, or may be used as a solid (powder) obtained by a method such as reprecipitation.
[0159] The ratio of the structural units derived from (b) and (c) to the total molar number of all structural units constituting the above-mentioned copolymer is preferably 5 mol% to 95 mol% for the structural units derived from (b) and 5 mol% to 95 mol% for the structural units derived from (c), and more preferably 10 mol% to 90 mol% for the structural units derived from (b) and 10 mol% to 90 mol% for the structural units derived from (c).
[0160] Resin [K3] can be obtained by reacting a cyclic ether derived from (b) contained in a copolymer of (b) and (c) with a carboxylic acid or carboxylic anhydride contained in (a) under the same conditions as in the production method of resin [K2].
[0161] The amount of (a) to be reacted with the copolymer is preferably 5 to 80 mol relative to 100 mol of (b).
[0162] The resin [K4] is a resin obtained by further reacting the resin [K3] with a carboxylic acid anhydride. The hydroxyl group generated by the reaction of the cyclic ether with the carboxylic acid or the carboxylic acid anhydride is reacted with the carboxylic acid anhydride.
[0163] Examples of the carboxylic anhydride include maleic anhydride, citraconic anhydride, itaconic anhydride, 3-vinylphthalic anhydride, 4-vinylphthalic anhydride, 3,4,5,6-tetrahydrophthalic anhydride, 1,2,3,6-tetrahydrophthalic anhydride, dimethyltetrahydrophthalic anhydride, and 5,6-dicarboxybicyclo[2.2.1]hept-2-ene anhydride.
[0164] The amount of the carboxylic anhydride used is preferably 0.5 to 1 mol based on 1 mol of the amount of (a) used.
[0165] Examples of the resin [K1], resin [K2], resin [K3], and resin [K4] include resin [K1] such as benzyl (meth)acrylate / (meth)acrylic acid copolymer and styrene / (meth)acrylic acid copolymer; resins obtained by adding glycidyl (meth)acrylate to benzyl (meth)acrylate / (meth)acrylic acid copolymer, resins obtained by adding glycidyl (meth)acrylate to tricyclodecyl (meth)acrylate / styrene / (meth)acrylic acid copolymer, and resins obtained by adding glycidyl (meth)acrylate to tricyclodecyl (meth)acrylate / styrene / (meth)acrylic acid copolymer; ) benzyl acrylate / (meth)acrylic acid copolymer [K2]; resins obtained by reacting (meth)acrylic acid with a copolymer of tricyclodecyl (meth)acrylate / glycidyl (meth)acrylate, resins obtained by reacting (meth)acrylic acid with a copolymer of tricyclodecyl (meth)acrylate / styrene / glycidyl (meth)acrylate, etc. [K3]; resins obtained by reacting (meth)acrylic acid with a copolymer of tricyclodecyl (meth)acrylate / styrene / glycidyl (meth)acrylate, etc., and further reacting tetrahydrophthalic anhydride with a resin obtained by reacting (meth)acrylic acid with a copolymer of tricyclodecyl (meth)acrylate / glycidyl (meth)acrylate, etc. [K4], etc.
[0166] Among them, the resin (C) preferably includes at least one selected from the group consisting of the resin [K2], the resin [K3], and the resin [K4].
[0167] As a further example of resin (C), an alkali-soluble resin described in Japanese Patent Publication No. 2018-123274 can be cited. As the alkali-soluble resin, a polymer having a double bond in the side chain and a main chain containing a structural unit (α) represented by the following formula (I) and a structural unit (β) represented by the following formula (II), and further containing an acid group (hereinafter also referred to as "resin (Ca)").
[0168] The acid group can be introduced into the resin by, for example, including a structural unit (γ) derived from an acid group-containing monomer (eg, (meth)acrylic acid). The resin (Ca) preferably includes structural units (α), (β), and (γ) in the main chain skeleton.
[0169]
[0170] [Where R A and R B are the same or different and represent a hydrogen atom or a hydrocarbon group having 1 to 25 carbon atoms. n represents the average number of repeating units of the structural unit represented by formula (I) and is a number greater than 1.]
[0171]
[0172] [Where R C The same or different, represents a hydrogen atom or a methyl group. D are the same or different and represent a linear or branched hydrocarbon group having 4 to 20 carbon atoms. m represents the average number of repeating units of the structural unit represented by formula (II) and is a number greater than 1.]
[0173] From the viewpoint of heat resistance and storage stability of the resin (Ca), the content ratio of the structural unit (α) in the resin (Ca) is, for example, 0.5% to 50% by mass, preferably 1% to 40% by mass, and more preferably 5% to 30% by mass, relative to the total amount 100% by mass of all monomer units providing the main chain skeleton of the resin (Ca). n in formula (I) represents the average number of repeating units of the structural unit (α) in the resin (Ca), and n can be set so that the content ratio of the structural unit (α) is within the above range.
[0174] From the viewpoint of solvent resistance of the cured film, the content ratio of the structural unit (β) is, for example, 10% to 90% by mass, preferably 20% to 80% by mass, and more preferably 30% to 75% by mass, relative to the total amount 100% by mass of all monomer units providing the main chain skeleton of the resin (Ca). m in formula (II) represents the average number of repeating units of the structural unit (β) in the resin (Ca), and m can be set so that the content ratio of the structural unit (β) is within the above range.
[0175] From the viewpoint of the solubility of the resin (Ca) in the alkaline substance and the solubility of the resin (Ca) in the solvent (G), the content ratio of the structural unit (γ) is, for example, 0.5% by mass to 50% by mass, preferably 2% by mass to 50% by mass, and more preferably 5% by mass to 45% by mass, relative to 100% by mass of the total amount of all monomer units providing the main chain skeleton of the resin (Ca).
[0176] The resin (C) may include one or more selected from the group consisting of the above-mentioned resin [K1], resin [K2], resin [K3], resin [K4] and resin (Ca).
[0177] As a further example of the resin (C), a polyalkylene glycol compound can be mentioned. Examples of the polyalkylene glycol compound include polyethylene glycol and polypropylene glycol. The polyalkylene glycol compound is advantageous in further improving the dispersibility of the quantum dots (A) in the curable resin composition.
[0178] The weight average molecular weight of the resin (C) measured by GPC in terms of standard polystyrene is preferably 9000 or less. When the resin (C) has such a weight average molecular weight, the development speed of the curable resin composition tends to be increased, and a cured film having high luminescence intensity can be obtained.
[0179] The standard polystyrene-equivalent weight average molecular weight of the resin (C) is, for example, 1,000 to 9,000, preferably 2,000 to 8,500, and more preferably 3,000 to 8,500 from the viewpoint of the development speed of the curable resin composition and the light emission intensity of the cured film.
[0180] The standard polystyrene-equivalent weight average molecular weight of the resin (C) is measured according to the measurement method described in the section of Examples below.
[0181] In order to adjust the weight average molecular weight of the resin (C) within the above range, the reaction conditions such as the selection of the raw materials used, the charging method, the reaction temperature and time can be appropriately combined and adjusted.
[0182] The molecular weight distribution [weight average molecular weight (Mw) / number average molecular weight (Mn)] of the resin (C) measured by GPC is, for example, 1.0 to 6.0, and preferably 1.2 to 4.0 from the viewpoint of developability of the curable resin composition.
[0183] When the resin (C) is one or more selected from the above-mentioned resin [K1], resin [K2], resin [K3], resin [K4] and resin (Ca), the acid value of the resin (C) is preferably 90 mgKOH / g to 150 mgKOH / g based on the solid content. When the acid value is less than 90 mgKOH / g, the solubility of the curable resin composition in the alkaline developer becomes low, and there is a possibility that residues remain on the substrate. When the acid value exceeds 150 mgKOH / g, the possibility of peeling of the cured pattern obtained by development becomes high.
[0184] The acid value of the resin (C) is preferably 95 mgKOH / g to 140 mgKOH / g, and more preferably 100 mgKOH / g to 130 mgKOH / g, from the viewpoint of the developability of the curable resin composition.
[0185] The acid value is a value measured as the amount (mg) of potassium hydroxide required to neutralize 1 g of the resin (C), and can be determined, for example, by titration using an aqueous potassium hydroxide solution. The acid value of the resin (C) is measured by the measurement method described in the Examples section below.
[0186] When resin (C) is one or more selected from the above-mentioned resins [K1], [K2], [K3], [K4] and resin (Ca), resin (C) may contain a resin having a double bond equivalent of, for example, 300 g / eq to 2000 g / eq, preferably 500 g / eq to 1500 g / eq. When resin (C) contains a resin having a double bond equivalent of 300 g / eq to 2000 g / eq, there is a tendency to easily prevent the phenomenon of being extinct in the process of manufacturing a cured pattern. When resin (C) contains a resin having a double bond equivalent of more than 2000 g / eq, there is a tendency for the ability of resin (C) to effectively protect quantum dots (A) to decrease. When resin (C) contains a resin having a double bond equivalent of less than 300 g / eq, there is a tendency that the cured pattern becomes easily peeled off due to insolubility during development.
[0187] As the resin having a double bond equivalent of 300 g / eq to 2000 g / eq, a (meth)acrylic resin can be cited. When the resin (C) is one or more selected from the above-mentioned resins [K1], [K2], [K3], [K4] and resin (Ca), the resin (C) is preferably composed of a (meth)acrylic resin.
[0188] The content of the resin (C) in the curable resin composition is, for example, 5% to 80% by mass, preferably 10% to 70% by mass, more preferably 13% to 60% by mass, and further preferably 17% to 55% by mass, relative to the total amount of the solid content of the curable resin composition. When the content of the resin (C) is within the above range, there is a tendency that the quantum dots (A) are easily dispersed and a high luminous efficiency is easily maintained in the process of manufacturing the cured pattern.
[0189] In the curable resin composition, the mass ratio (solid content ratio) of the resin (C) to the photopolymerizable compound (D) described later is, for example, 1 or more, preferably 1.5 or more, more preferably 2 or more, and further preferably 2.5 or more from the viewpoint of the developability of the curable resin composition and the luminous intensity of the cured film.
[0190] [5] Photopolymerizable compound (D)
[0191] The photopolymerizable compound (D) is a compound that can be polymerized by active radicals, acids, etc. generated from a photopolymerization initiator (E) described below, and examples thereof include compounds having an ethylenically unsaturated bond, and are preferably (meth)acrylate compounds.
[0192] Among them, the photopolymerizable compound (D) is preferably a polymerizable compound having three or more ethylenically unsaturated bonds. The weight average molecular weight of the photopolymerizable compound (D) is preferably 150 to 2,900, more preferably 250 to 1,500.
[0193] Examples of polymerizable compounds having three or more ethylenically unsaturated bonds include photopolymerizable compounds (Da) having three or more ethylenically unsaturated bonds in the molecule and having a carboxyl group, and photopolymerizable compounds (Db) having three or more ethylenically unsaturated bonds in the molecule and not having a carboxyl group. The photopolymerizable compound (D) preferably includes at least one of the photopolymerizable compound (Da) and the photopolymerizable compound (Db), and may also include two or more photopolymerizable compounds (Da), two or more photopolymerizable compounds (Db), or at least one photopolymerizable compound (Da) and at least one photopolymerizable compound (Db).
[0194] By making the photopolymerizable compound (D) contain the photopolymerizable compound (Da), the dispersibility of the quantum dots (A) in the curable resin composition can be improved, thereby increasing the luminous intensity of the cured film. In addition, by making the photopolymerizable compound (D) contain the photopolymerizable compound (Da), the curability and heat resistance of the curable resin composition can be improved.
[0195] The ethylenically unsaturated bond of the photopolymerizable compound (Da) is preferably a (meth)acryloyloxy group. The number of ethylenically unsaturated bonds in one molecule of the photopolymerizable compound (Da) is preferably 3 to 5, more preferably 3. The number of carboxyl groups in one molecule of the photopolymerizable compound (Da) is preferably 1.
[0196] As the photopolymerizable compound (Da), there can be mentioned compounds obtained by polyacid modification of compounds having three or more (meth)acryloyloxy groups and hydroxyl groups, such as pentaerythritol tri(meth)acrylate or dipentaerythritol penta(meth)acrylate. As such compounds, for example, there can be mentioned compounds obtained by monoesterification of pentaerythritol tri(meth)acrylate with succinic acid, compounds obtained by monoesterification of dipentaerythritol penta(meth)acrylate with succinic acid, compounds obtained by monoesterification of pentaerythritol tri(meth)acrylate with maleic acid, compounds obtained by monoesterification of dipentaerythritol penta(meth)acrylate with maleic acid, etc. Among them, compounds obtained by monoesterification of pentaerythritol tri(meth)acrylate with succinic acid are preferred.
[0197] The ethylenically unsaturated bond contained in the photopolymerizable compound (Db) is preferably a (meth)acryloyloxy group. The number of ethylenically unsaturated bonds contained in one molecule of the photopolymerizable compound (Db) is preferably 3 to 6.
[0198] Examples of the photopolymerizable compound (Db) include trimethylolpropane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, dipentaerythritol penta(meth)acrylate, dipentaerythritol hexa(meth)acrylate, tripentaerythritol octa(meth)acrylate, tripentaerythritol hepta(meth)acrylate, tetrapentaerythritol deca(meth)acrylate, tetrapentaerythritol nona(meth)acrylate, tris(2-(meth)acryloyloxyethyl)isocyanurate, ethylene glycol-modified pentaerythritol tetra(meth)acrylate, ethylene glycol-modified dipentaerythritol hexa(meth)acrylate, propylene glycol-modified pentaerythritol tetra(meth)acrylate, propylene glycol-modified dipentaerythritol hexa(meth)acrylate, caprolactone-modified pentaerythritol tetra(meth)acrylate, and caprolactone-modified dipentaerythritol hexa(meth)acrylate. Among them, dipentaerythritol penta(meth)acrylate, dipentaerythritol hexa(meth)acrylate, and the like are preferred.
[0199] The content of the photopolymerizable compound (D) in the curable resin composition is preferably 7% to 60% by mass, more preferably 10% to 45% by mass, and further preferably 13% to 30% by mass relative to the total amount of the solid content of the curable resin composition. When the content of the photopolymerizable compound (D) is within the above range, there is a tendency for the solvent resistance (residual film rate) of the cured film to be improved.
[0200] From the viewpoint of increasing the development speed of the curable resin composition, the content of the photopolymerizable compound (D) is preferably 13% by mass or more, more preferably 15% by mass or more, and further preferably 20% by mass or more relative to the total solid content of the curable resin composition.
[0201] From the viewpoint of increasing the developing speed of the curable resin composition, the photopolymerizable compound (D) preferably contains 50% by mass or more of the photopolymerizable compound (Db). From the viewpoint of increasing the solvent resistance (residual film rate) of the cured film, the photopolymerizable compound (D) preferably contains the photopolymerizable compound (Da) and the photopolymerizable compound (Db).
[0202] [6] Photopolymerization initiator (E)
[0203] The photopolymerization initiator (E) is a compound that generates active radicals, acids, etc. by the action of light or heat to initiate polymerization.
[0204] The photopolymerization initiator (E) preferably contains an oxime compound having a first molecular structure represented by the following formula (1). Hereinafter, the oxime compound is also referred to as "oxime compound (1)".
[0205]
[0206] From the viewpoint of improving the luminous intensity (brightness) of the cured film, it is advantageous to include an oxime compound (1) as a photopolymerization initiator (E). It is speculated that one factor that can produce such an effect is that due to the unique molecular structure of the oxime compound (1), the absorption wavelength of the oxime compound (1) changes greatly before and after the cleavage (decomposition) of the oxime compound (1) required for the oxime compound (1) to initiate photopolymerization, and therefore the oxime compound (1) has a high ability to initiate photoradical polymerization.
[0207] In formula (1), R 1 Represents R 11 , OR 11 , COR 11 , SR 11 ,CONR 12 R 13 or CN.
[0208] R 11 , R 12 and R 13 Each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an aralkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms.
[0209] R 11 , R 12 or R 13 The hydrogen atoms of the group represented by OR 21 , COR 21 , SR 21 NR 22 Ra 23 ,CONR 22 R 23 , -NR 22 -OR 23 , -N(COR 22 )-OCOR 23 、-C(=N-OR 21 )-R 22 、-C(=N-OCOR 21 )-R 22 , CN, halogen atoms, or COOR 21 replace.
[0210] R 21 , R 22 and R 23 Each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an aralkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms.
[0211] R 21 , R 22 or R 23 The hydrogen atom of the group represented may be substituted with CN, a halogen atom, a hydroxyl group, or a carboxyl group.
[0212] R 11 , R 12 , R 13 , R 21 , R 22 or R 23 When the group represented by has an alkylene moiety, the alkylene moiety may be represented by -O-, -S-, -COO-, -OCO-, -NR 24 -, -NR 24 CO-、-NR 24 COO-、-OCONR 24 -, -SCO-, -COS-, -OCS-, or -CSO- interrupts 1 to 5 times.
[0213] R 24 It represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an aralkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms.
[0214] R 11 , R 12 , R 13 , R 21 , R 22 or R 23 When the group represented by has an alkyl portion, the alkyl portion may be branched or cyclic. 12 With R 13 and R 22 With R 23 They can each form a ring together.
[0215] * represents a bonding site to another molecular structure other than the first molecular structure of the oxime compound (1), that is, the second molecular structure.
[0216] As R in formula (1) 11 , R 12 , R 13 , R 21 , R 22 , R 23 and R 24The alkyl group having 1 to 20 carbon atoms represented by is, for example, a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a pentyl group, an isopentyl group, a tert-pentyl group, a hexyl group, a heptyl group, an octyl group, an isooctyl group, a 2-ethylhexyl group, a tert-octyl group, a nonyl group, an isononyl group, a decyl group, an isodecyl group, an undecyl group, a dodecyl group, a tetradecyl group, a hexadecyl group, an octadecyl group, an eicosyl group, a cyclopentyl group, a cyclohexyl group, a cyclohexylmethyl group, a cyclohexylethyl group, and the like.
[0217] As R in formula (1) 11 , R 12 , R 13 , R 21 , R 22 , R 23 and R 24 Examples of the aryl group having 6 to 30 carbon atoms represented by phenyl include phenyl, tolyl, xylyl, ethylphenyl, naphthyl, anthracenyl, phenanthryl, and phenyl substituted with one or more of the above alkyl groups, biphenyl, naphthyl, anthracenyl, and the like.
[0218] As R in formula (1) 11 , R 12 , R 13 , R 21 , R 22 , R 23 and R 24 Examples of the aralkyl group having 7 to 30 carbon atoms represented by alkyl include benzyl, α-methylbenzyl, α,α-dimethylbenzyl, and phenylethyl.
[0219] As R in formula (1) 11 , R 12 , R 13 , R 21 , R 22 , R 23 and R 24 The heterocyclic group having 2 to 20 carbon atoms represented by the present invention includes, for example, pyridyl, pyrimidinyl, furanyl, thienyl, tetrahydrofuranyl, dioxolanyl, benzo Oxazol-2-yl, tetrahydropyranyl, pyrrolidinyl, imidazolidinyl, pyrazolidinyl, thiazolidinyl, isothiazolidinyl, Oxazolidinyl, isocyanate The rings include oxazolidinyl, piperidinyl, piperazinyl and morpholinyl, and preferably are 5- to 7-membered heterocyclic rings.
[0220] R in formula (1) 12 With R 13 and R 22 With R 23 can form a ring together respectively refers to R 12 With R 13 and R 22 With R23 They can form a ring together with the nitrogen atom, carbon atom or oxygen atom to which they are connected.
[0221] As Ra in formula (1) 12 With Ra 13 and Ra 22 With Ra 23 Examples of the ring that can be formed together include a cyclopentane ring, a cyclohexane ring, a cyclopentene ring, a benzene ring, a piperidine ring, a morpholine ring, a lactone ring, a lactam ring and the like, and a five- to seven-membered ring is preferred.
[0222] For R in formula (1) 11 , R 12 , R 13 , R 21 , R 22 and R 23 Examples of the halogen atom which may be possessed by the substituent include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
[0223] R in formula (1) 1 Preferably R 11 , more preferably an alkyl group having 1 to 20 carbon atoms, further preferably an alkyl group having 1 to 10 carbon atoms, and further preferably an alkyl group having 1 to 6 carbon atoms.
[0224] An example of the second molecular structure connected to the first molecular structure represented by formula (1) is a structure represented by the following formula (2): The second molecular structure refers to another molecular structure portion of the oxime compound (1) other than the first molecular structure.
[0225] The bonding site represented by "*" in formula (2) is directly bonded to the bonding site represented by "*" in formula (1). That is, when the second molecular structure is the structure represented by formula (2), the benzene ring having "-*" in formula (2) is directly bonded to the carbonyl group having "-*" in formula (1).
[0226]
[0227] In formula (2), R 2 and R 3 Each independently represents R 11 , OR 11 , SR 11 , COR 11 ,CONR 12 R 13 NR 12 COR 11 ,OCOR 11 、COOR 11 SCOR 11 , OCSR 11 、COSR11 ,CSOR 11 , CN, or a halogen atom.
[0228] R 2 When there are multiple ones, they may be the same or different.
[0229] R 3 When there are multiple ones, they may be the same or different.
[0230] R 11 , R 12 and R 13 Means the same as above.
[0231] s and t each independently represent an integer of 0-4.
[0232] L represents a sulfur atom, CR 31 R 32 , CO or NR 33 .
[0233] R 31 , R 32 and R 33 Each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, or an aralkyl group having 7 to 30 carbon atoms.
[0234] R 31 , R 32 or R 33 When the group represented by has an alkyl portion, the alkyl portion may be branched or cyclic. 31 , R 32 and R 33 Each of them can independently form a ring together with an adjacent benzene ring.
[0235] R 4 It represents a hydroxyl group, a carboxyl group or a group represented by the following formula (2-1).
[0236] (R 4a ) v -L 2 -L 1 (2-1)
[0237] (In formula (2-1), L 1 Indicates -O-, -S-, -NR 22 -, -NR 22 CO-, -SO2-, -CS-, -OCO- or -COO-.
[0238] R 22 Means the same as above.
[0239] L 2 It represents a group obtained by removing v hydrogen atoms from an alkyl group having 1 to 20 carbon atoms, a group obtained by removing v hydrogen atoms from an aryl group having 6 to 30 carbon atoms, a group obtained by removing v hydrogen atoms from an aralkyl group having 7 to 30 carbon atoms, or a group obtained by removing v hydrogen atoms from a heterocyclic group having 2 to 20 carbon atoms.
[0240] L 2 When the group represented by has an alkylene moiety, the alkylene moiety may be represented by -O-, -S-, -COO-, -OCO-, -NR 22 -, -NR 22 COO-、-OCONR 22 -, -SCO-, -COS-, -OCS- or -CSO- is interrupted 1 to 5 times, and the alkylene part may be branched or cyclic.
[0241] R 4a Represents OR 41 , SR 41 ,CONR 42 R 43 NR 42 COR 43 ,OCOR 41 、COOR 41 SCOR 41 , OCSR 41 、COSR 41 ,CSOR 41 , CN, or a halogen atom.
[0242] R 4a When there are multiple ones, they may be the same or different.
[0243] R 41 , R 42 and R 43 each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, or an aralkyl group having 7 to 30 carbon atoms, and R 41 , R 42 and R 43 When the group represented by has an alkyl portion, the alkyl portion may be branched or cyclic. 42 With R 43 Can form a ring together.
[0244] v represents an integer from 1 to 3. )
[0245] * represents a bonding site to the first molecular structure of the oxime compound (1).
[0246] R in formula (2) 11, R 12 , R 13 , R 21 , R 22 , R 23 , R 24 , R 31 , R 32 and R 33 , and R in the above formula (2-1) 22 , R 41 , R 42 and R 43 Examples of the alkyl group having 1 to 20 carbon atoms, the aryl group having 6 to 30 carbon atoms, and the aralkyl group having 7 to 30 carbon atoms represented by 11 , R 12 , R 13 , R 21 , R 22 , R 23 and R 24 The same example.
[0247] R in formula (2) 11 , R 12 , R 13 , R 21 , R 22 , R 23 , R 24 , and R in the above formula (2-1) 22 Examples of heterocyclic groups having 2 to 20 carbon atoms are the same as those for R in formula (1). 11 , R 12 , R 13 , R 21 , R 22 , R 23 and R 24 The same example.
[0248] R in formula (2) 31 , R 32 and R 33 Each of the two rings can independently form a ring with an adjacent benzene ring. 31 , R 32 and R 33 Each of them can independently form a ring together with an adjacent benzene ring and the nitrogen atom to which it is connected.
[0249] R in formula (2) 31 , R 32 and R 33 Examples of the ring that can be formed with an adjacent benzene ring are similar to those for Ra in formula (1). 12 With Ra 13 and Ra 22 With Ra23 The same is true for examples of rings that can be formed together.
[0250] In the above formula (2-1), L 2 It represents a group obtained by removing v hydrogen atoms from an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an aralkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms.
[0251] Examples of the group obtained by removing v hydrogen atoms from an alkyl group having 1 to 20 carbon atoms include, for example, a methylene group, an ethylene group, a propylene group, a methylethylene group, a butylene group, a 1-methylpropylene group, a 2-methylpropylene group, a 1,2-dimethylpropylene group, a 1,3-dimethylpropylene group, a 1-methylbutylene group, a 2-methylbutylene group, a 3-methylbutylene group, a 4-methylbutylene group, a 2,4-dimethylbutylene group, a 1,3-dimethylbutylene group, a pentylene group, a hexylene group, a heptylene group, an octylene group, a nonylene group, a decylene group, a dodecylene group, a tridecylene group, a tetradecylene group, a pentadecylene group, an ethane-1,1-diyl group, and a propane-2,2-diyl group.
[0252] Examples of the group obtained by removing v hydrogen atoms from an aryl group having 6 to 30 carbon atoms include, when v is 1, 1,2-phenylene, 1,3-phenylene, 1,4-phenylene, 2,6-naphthylene, 1,4-naphthylene, 2,5-dimethyl-1,4-phenylene, diphenylmethane-4,4'-diyl, 2,2-diphenylpropane-4,4'-diyl, diphenylsulfide-4,4'-diyl, and diphenylsulfone-4,4'-diyl.
[0253] Examples of the group obtained by removing v hydrogen atoms from an aralkyl group having 7 to 30 carbon atoms include, when v is 1, a group represented by the following formula (a) and a group represented by the following formula (b).
[0254]
[0255] [In formulas (a) and (b), L 3 and L 5 represents an alkylene group having 1 to 10 carbon atoms, L 4 and L 6 represents a single bond or an alkylene group having 1 to 10 carbon atoms.]
[0256] Examples of the alkylene group having 1 to 10 carbon atoms include methylene, ethylene, propylene, methylethylene, butylene, 1-methylpropylene, 2-methylpropylene, 1,2-dimethylpropylene, 1,3-dimethylpropylene, 1-methylbutylene, 2-methylbutylene, 3-methylbutylene, 4-methylbutylene, 2,4-dimethylbutylene, 1,3-dimethylbutylene, pentylene, hexylene, heptylene, octylene, nonylene, and decylene.
[0257] Examples of the group obtained by removing v hydrogen atoms from a heterocyclic group having 2 to 20 carbon atoms include, for example, when v is 1, 2,5-pyridinediyl, 2,6-pyridinediyl, 2,5-pyrimidinediyl, 2,5-thiophenediyl, 3,4-tetrahydrofurandiyl, 2,5-tetrahydrofurandiyl, 2,5-furandiyl, 3,4-thiazolediyl, 2,5-benzofurandiyl, 2,5-benzothiophenediyl, N-methylindole-2,5-diyl, 2,5-benzothiazolediyl, 2,5-benzo A di-membered heterocyclic group such as oxadiyl.
[0258] As R in formula (2) 2 and R 3 , and R in the above formula (2-1) 4a Examples of the halogen atom represented by include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
[0259] From the viewpoint of solubility in the solvent (G) and / or the development speed of the curable resin composition, a preferred example of the structure represented by formula (2) is a structure represented by the following formula (2a).
[0260]
[0261] [In formula (2a), L' represents a sulfur atom or NR 50 , R 50 represents a linear, branched or cyclic alkyl group having 1 to 20 carbon atoms, R 2 , R 3 , R 4 , s and t have the same meanings as above.]
[0262] From the same viewpoint as above, another preferred example of the structure represented by formula (2) is a structure represented by the following formula (2b).
[0263]
[0264] [In formula (2b), R 44 It represents a hydroxyl group, a carboxyl group, or a group represented by the following formula (2-2).
[0265] R 44a-L 12 -L 11 - (2-2)
[0266] (In formula (2-2), L 11 Indicates -O- or *-OCO-, * indicates L 12 The bonding site, L 12 represents an alkylene group having 1 to 20 carbon atoms, which may be interrupted by 1 to 3 -O- groups, R 44a Represents OR 55 or COOR 55 , R 55 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms. )]
[0267] R 44 The group represented by the formula (2-2) is preferred. In this case, it is advantageous in terms of the solubility of the oxime compound (1) in the solvent (G) and the development speed of the curable resin composition.
[0268] L 12 The alkylene group represented by is preferably 1-10, more preferably 1-4.
[0269] R 44a It is preferably a hydroxyl group or a carboxyl group, and more preferably a hydroxyl group.
[0270] The method for producing the oxime compound (1) having the second molecular structure represented by the formula (2) is not particularly limited, and for example, it can be produced by the method described in JP-A-2011-132215.
[0271] Another example of the second molecular structure connected to the first molecular structure represented by formula (1) is a structure represented by the following formula (3).
[0272] The bonding site represented by "*" in formula (3) is directly bonded to the bonding site represented by "*" in formula (1). That is, when the second molecular structure is the structure represented by formula (3), the benzene ring having "-*" in formula (3) is directly bonded to the carbonyl group having "-*" in formula (1).
[0273]
[0274] In formula (3), R 5 It represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms.
[0275] R 5 When the group represented by has an alkyl portion, the alkyl portion may be branched or cyclic.
[0276] R5 The hydrogen atoms of the group represented by R 21 , OR 21 , COR 21 , SR 21 NR 22 R 23 ,CONR 22 R 23 , -NR 22 -OR 23 , -N(COR 22 )-OCOR 23 NR 22 COR 21 ,OCOR 21 、COOR 21 、-C(=N-OR 21 )-R 22 、-C(=N-OCOR 21 )-R 22 SCOR 21 , OCSR 21 、COSR 21 ,CSOR 21 , hydroxyl, nitro, CN, halogen atoms, or COOR 21 replace.
[0277] R 21 , R 22 and R 23 Means the same as above.
[0278] R 21 , R 22 or R 23 The hydrogen atom of the group represented may be substituted with CN, a halogen atom, a hydroxyl group, or a carboxyl group.
[0279] R 21 , R 22 and R 23 When the group represented by has an alkylene moiety, the alkylene moiety may be represented by -O-, -S-, -COO-, -OCO-, -NR 24 -, -NR 24 CO-、-NR 24 COO-、-OCONR 24 -, -SCO-, -COS-, -OCS-, or -CSO- interrupts 1 to 5 times.
[0280] R 24 Means the same as above.
[0281] R 21 , R 22 and R 23When the group represented by has an alkyl portion, the alkyl portion may be branched or cyclic. 22 With R 23 Can form a ring together.
[0282] R 6 , R 7 , R 8 and R 9 Each independently represents R 61 , OR 61 , SR 61 , COR 62 ,CONR 63 R 64 NR 65 COR 61 ,OCOR 61 、COOR 62 SCOR 61 , OCSR 61 、COSR 62 ,CSOR 61 , hydroxyl, nitro, CN, or halogen atoms.
[0283] R 61 , R 62 , R 63 , R 64 and R 65 Each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms.
[0284] R 61 , R 62 , R 63 , R 64 or R 65 The hydrogen atoms of the group represented by OR 21 , COR 21 , SR 21 NR 22 Ra 23 ,CONR 22 R 23 , -NR 22 -OR 23 , -N(COR 22 )-OCOR 23 、-C(=N-OR 21 )-R 22 、-C(=N-OCOR 21 )-R 22 , CN, halogen atoms, or COOR 21 replace.
[0285] R 6 With R 7 , R 7 With R 8 , and R 8 With R 9 They can each form a ring together.
[0286] * represents a bonding site to the first molecular structure of the oxime compound (1).
[0287] R in formula (3) 5 , R 21 , R 22 , R 23 , R 24 , R 61 , R 62 , R 63 , R 64 and R 65 Examples of the alkyl group having 1 to 20 carbon atoms, the aryl group having 6 to 30 carbon atoms, the aralkyl group having 7 to 30 carbon atoms, and the heterocyclic group having 2 to 20 carbon atoms represented by 11 , R 12 , R 13 , R 21 , R 22 , R 23 and R 24 The same example.
[0288] R in formula (3) 22 With R 23 Can form a ring together refers to R 22 With R 23 They may form a ring together with the nitrogen atom, carbon atom or oxygen atom to which they are attached.
[0289] R in formula (3) 22 With R 23 Examples of rings that can be formed together are similar to those for Ra in formula (1). 12 With Ra 13 and Ra 22 With Ra 23 The same is true for the examples of rings that can be formed together.
[0290] As R in formula (3) 6 , R 7 , R 8 and R 9 The halogen atom represented by R 5 , R 21 , R 22 , R 23 , R 61 , R 62 , R63 , R 64 and R 65 Examples of the halogen atom replacing the hydrogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
[0291] From the viewpoint of solubility in the solvent (G) and / or development speed of the curable resin composition, in a preferred embodiment, R 5 It is a group represented by the following formula (3-1).
[0292]
[0293] [In the formula (3-1), Z represents a group obtained by removing one hydrogen atom from an alkyl group having 1 to 20 carbon atoms, a group obtained by removing one hydrogen atom from an aryl group having 6 to 30 carbon atoms, a group obtained by removing one hydrogen atom from an aralkyl group having 7 to 30 carbon atoms, or a group obtained by removing one hydrogen atom from a heterocyclic group having 2 to 20 carbon atoms,
[0294] When the group represented by Z has an alkylene moiety, the alkylene moiety may be -O-, -S-, -COO-, -OCO-, -NR 24 -, -NR 24 COO-、-OCONR 24 -, -SCO-, -COS-, -OCS- or -CSO- are interrupted 1 to 5 times, and the alkylene part may be branched or cyclic.
[0295] R 21 , R 22 and R 24 Means the same as above.]
[0296] From the same viewpoint as described above, Z in formula (3-1) is preferably a methylene group, an ethylene group, or a phenylene group.
[0297] From the same point of view as above, R in formula (3-1) 21 and R 22 It is preferably an alkyl group having 1 to 20 carbon atoms or an aryl group having 6 to 30 carbon atoms, and more preferably a methyl group, an ethyl group or a phenyl group.
[0298] From the same viewpoint as above, in another preferred embodiment, R 7 For nitro.
[0299] The method for producing the oxime compound (1) having the second molecular structure represented by formula (3) is not particularly limited, and for example, it can be produced by the methods described in JP-A-2000-80068 and JP-A-2011-178776.
[0300] Another example of the second molecular structure connected to the first molecular structure represented by formula (1) is a structure represented by the following formula (4).
[0301] The bonding site represented by "*" in formula (4) is directly bonded to the bonding site represented by "*" in formula (1). That is, when the second molecular structure is the structure represented by formula (4), the benzene ring having "-*" in formula (4) is directly bonded to the carbonyl group having "-*" in formula (1).
[0302]
[0303] In formula (4), R 71 It represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an aralkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms.
[0304] R 71 When the group represented by has an alkyl portion, the alkyl portion may be branched or cyclic.
[0305] R 71 The hydrogen atoms of the group represented by R 21 , OR 21 , COR 21 , SR 21 NR 22 R 23 ,CONR 22 R 23 , -NR 22 -OR 23 , -N(COR 22 )-OCOR 23 NR 22 COR 21 ,OCOR 21 、COOR 21 、-C(=N-OR 21 )-R 22 、-C(=N-OCOR 21 )-R 22 SCOR 21 , OCSR 21 、COSR 21 ,CSOR 21 , hydroxyl, nitro, CN, halogen atoms, or COOR 21 replace.
[0306] R 21 , R 22 and R 23 Means the same as above.
[0307] R21 , R 22 or R 23 The hydrogen atom of the group represented may be substituted with CN, a halogen atom, a hydroxyl group, or a carboxyl group.
[0308] R 21 , R 22 and R 23 When the group represented by has an alkylene moiety, the alkylene moiety may be represented by -O-, -S-, -COO-, -OCO-, -NR 24 -, -NR 24 CO-、-NR 24 COO-、-OCONR 24 -, -SCO-, -COS-, -OCS-, or -CSO- interrupts 1 to 5 times.
[0309] R 24 Means the same as above.
[0310] R 21 , R 22 and R 23 When the group represented by has an alkyl portion, the alkyl portion may be branched or cyclic. 22 With R 23 Can form a ring together.
[0311] R 72 , R 73 and 3 Rs 74 Each independently represents R 61 , OR 61 , SR 61 , COR 62 ,CONR 63 R 64 NR 65 COR 61 ,OCOR 61 、COOR 62 SCOR 61 , OCSR 61 、COSR 62 ,CSOR 61 , hydroxyl, nitro, CN, or halogen atoms.
[0312] R 61 , R 62 , R 63 , R 64 and R 65 Each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms.
[0313] R 61 , R 62 , R 63 , R 64 or R 65 The hydrogen atoms of the group represented by OR 21 , COR 21 , SR 21 NR 22 Ra 23 ,CONR 22 R 23 , -NR 22 -OR 23 , -N(COR 22 )-OCOR 23 、-C(=N-OR 21 )-R 22 、-C(=N-OCOR 21 )-R 22 , CN, halogen atoms, or COOR 21 replace.
[0314] R 72 With R 73 and 2 R 74 They can each form a ring together.
[0315] * represents a bonding site to the first molecular structure of the oxime compound (1).
[0316] R in formula (4) 71 , R 21 , R 22 , R 23 , R 24 , R 61 , R 62 , R 63 , R 64 and R 65 Examples of the alkyl group having 1 to 20 carbon atoms, the aryl group having 6 to 30 carbon atoms, the aralkyl group having 7 to 30 carbon atoms, and the heterocyclic group having 2 to 20 carbon atoms represented by 11 , R 12 , R 13 , R 21 , R 22 , R 23 and R 24 The same example.
[0317] R in formula (4) 22 With R 23 Can form a ring together refers to R 22 With R 23They may form a ring together with the nitrogen atom, carbon atom or oxygen atom to which they are attached.
[0318] R in formula (4) 22 With R 23 Examples of rings that can be formed together are similar to those for Ra in formula (1). 12 With Ra 13 and Ra 22 With Ra 23 The same is true for the examples of rings that can be formed together.
[0319] As R in formula (4) 72 , R 73 and R 74 The halogen atom represented by R 71 , R 21 , R 22 , R 23 , R 61 , R 62 , R 63 , R 64 and R 65 Examples of the halogen atom replacing the hydrogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
[0320] The method for producing the oxime compound (1) having the second molecular structure represented by formula (4) is not particularly limited, and for example, it can be produced by the methods described in International Publication Nos. 2017 / 051680 and 2020 / 004601.
[0321] Another example of the second molecular structure connected to the first molecular structure represented by formula (1) is a structure represented by the following formula (5).
[0322] The bonding site represented by "*" in formula (5) is directly bonded to the bonding site represented by "*" in formula (1). That is, when the second molecular structure is the structure represented by formula (5), the pyrrole ring having "-*" in formula (5) is directly bonded to the carbonyl group having "-*" in formula (1).
[0323]
[0324] In formula (5), R 81 It represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an aralkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms.
[0325] R 81 When the group represented by has an alkyl portion, the alkyl portion may be branched or cyclic.
[0326] R 81The hydrogen atoms of the group represented by R 21 , OR 21 , COR 21 , SR 21 NR 22 R 23 ,CONR 22 R 23 , -NR 22 -OR 23 , -N(COR 22 )-OCOR 23 NR 22 COR 21 ,OCOR 21 、COOR 21 、-C(=N-OR 21 )-R 22 、-C(=N-OCOR 21 )-R 22 SCOR 21 , OCSR 21 、COSR 21 ,CSOR 21 , hydroxyl, nitro, CN, halogen atoms, or COOR 21 replace.
[0327] R 21 , R 22 and R 23 Means the same as above.
[0328] R 21 , R 22 or R 23 The hydrogen atom of the group represented may be substituted with CN, a halogen atom, a hydroxyl group, or a carboxyl group.
[0329] R 21 , R 22 and R 23 When the group represented by has an alkylene moiety, the alkylene moiety may be represented by -O-, -S-, -COO-, -OCO-, -NR 24 -, -NR 24 CO-、-NR 24 COO-、-OCONR 24 -, -SCO-, -COS-, -OCS-, or -CSO- interrupts 1 to 5 times.
[0330] R 24 Means the same as above.
[0331] R 21 , R 22 and R 23When the group represented by has an alkyl portion, the alkyl portion may be branched or cyclic. 22 With R 23 Can form a ring together.
[0332] R 82 , R 83 , R 84 , R 85 and R 86 Each independently represents R 61 , OR 61 , SR 61 , COR 62 ,CONR 63 R 64 NR 65 COR 61 ,OCOR 61 、COOR 62 SCOR 61 , OCSR 61 、COSR 62 ,CSOR 61 , hydroxyl, nitro, CN, or halogen atoms.
[0333] R 61 , R 62 , R 63 , R 64 and R 65 Each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms.
[0334] R 61 , R 62 , R 63 , R 64 or R 65 The hydrogen atoms of the group represented by OR 21 , COR 21 , SR 21 NR 22 Ra 23 ,CONR 22 R 23 , -NR 22 -OR 23 , -N(COR 22 )-OCOR 23 、-C(=N-OR 21 )-R 22 、-C(=N-OCOR 21 )-R 22 , CN, halogen atoms, or COOR 21 replace.
[0335] R 83 With R 84 , R 84 With R 85 , and R 85 With R 86 They can each form a ring together.
[0336] * represents a bonding site to the first molecular structure of the oxime compound (1).
[0337] R in formula (5) 81 , R 21 , R 22 , R 23 , R 24 , R 61 , R 62 , R 63 , R 64 and R 65 Examples of the alkyl group having 1 to 20 carbon atoms, the aryl group having 6 to 30 carbon atoms, the aralkyl group having 7 to 30 carbon atoms, and the heterocyclic group having 2 to 20 carbon atoms represented by 11 , R 12 , R 13 , R 21 , R 22 , R 23 and R 24 The same example.
[0338] R in formula (5) 22 With R 23 Can form a ring together refers to R 22 With R 23 They may form a ring together with the nitrogen atom, carbon atom or oxygen atom to which they are attached.
[0339] R in formula (5) 22 With R 23 Examples of rings that can be formed together are similar to those for Ra in formula (1). 12 With Ra 13 and Ra 22 With Ra 23 The same is true for the examples of rings that can be formed together.
[0340] As R in formula (5) 82 , R 83 , R 84 , R 85 and R 86 The halogen atom represented by R 81 , R 21 , R 22 , R 23 , R61 , R 62 , R 63 , R 64 and R 65 Examples of the halogen atom replacing the hydrogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
[0341] The method for producing the oxime compound (1) having the second molecular structure represented by formula (5) is not particularly limited, and for example, it can be produced by the methods described in International Publication Nos. 2017 / 051680 and 2020 / 004601.
[0342] Another example of the second molecular structure connected to the first molecular structure represented by formula (1) is a structure represented by the following formula (6).
[0343] The bonding site represented by "*" in formula (6) is directly bonded to the bonding site represented by "*" in formula (1). That is, when the second molecular structure is the structure represented by formula (6), the benzene ring having "-*" in formula (6) is directly bonded to the carbonyl group having "-*" in formula (1).
[0344]
[0345] In formula (6), the four R 91 , R 92 , R 93 , R 94 , R 95 , R 96 and R 97 Each independently represents R 61 , OR 61 , SR 61 , COR 62 ,CONR 63 R 64 NR 65 COR 61 ,OCOR 61 、COOR 62 SCOR 61 , OCSR 61 、COSR 62 ,CSOR 61 , hydroxyl, nitro, CN, or halogen atoms.
[0346] R 61 , R 62 , R 63 , R 64 and R 65Each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms.
[0347] R 61 , R 62 , R 63 , R 64 or R 65 The hydrogen atoms of the group represented by OR 21 , COR 21 , SR 21 NR 22 Ra 23 ,CONR 22 R 23 , -NR 22 -OR 23 , -N(COR 22 )-OCOR 23 、-C(=N-OR 21 )-R 22 、-C(=N-OCOR 21 )-R 22 , CN, halogen atoms, or COOR 21 replace.
[0348] R 21 , R 22 and R 23 Means the same as above.
[0349] R 92 With R 93 , R 94 With R 95 , R 95 With R 96 , and R 96 With R 97 They can each form a ring together.
[0350] * represents a bonding site to the first molecular structure of the oxime compound (1).
[0351] R in formula (6) 21 , R 22 , R 23 , R 61 , R 62 , R 63 , R 64 and R 65 Examples of the alkyl group having 1 to 20 carbon atoms, the aryl group having 6 to 30 carbon atoms, the aralkyl group having 7 to 30 carbon atoms, and the heterocyclic group having 2 to 20 carbon atoms represented by 11 , R 12, R 13 , R 21 , R 22 and R 23 The same example.
[0352] R in formula (6) 22 With R 23 Can form a ring together refers to R 22 With R 23 They may form a ring together with the nitrogen atom, carbon atom or oxygen atom to which they are attached.
[0353] R in formula (6) 22 With R 23 Examples of rings that can be formed together are similar to those for Ra in formula (1). 12 With Ra 13 and Ra 22 With Ra 23 The same is true for the examples of rings that can be formed together.
[0354] As R in formula (6) 91 , R 92 , R 93 , R 94 , R 95 , R 96 and R 97 The halogen atom represented by R 21 , R 22 , R 23 , R 61 , R 62 , R 63 , R 64 and R 65 Examples of the halogen atom replacing the hydrogen atom include a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
[0355] The method for producing the oxime compound (1) having the second molecular structure represented by formula (6) is not particularly limited, and for example, it can be produced by the methods described in International Publication Nos. 2017 / 051680 and 2020 / 004601.
[0356] The photopolymerization initiator (E) may further contain other photopolymerization initiators other than the oxime compound (1).
[0357] Examples of other photopolymerization initiators include oxime compounds other than the oxime compound (1), biimidazole compounds, triazine compounds, and acylphosphine compounds.
[0358] Examples of oxime compounds other than the oxime compound (1) include oxime compounds having a partial structure represented by the following formula (d1): * represents a bonding site.
[0359]
[0360] Examples of the oxime compound having a partial structure represented by formula (d1) include N-benzoyloxy-1-(4-phenylthiophenyl)butane-1-one-2-imine, N-benzoyloxy-1-(4-phenylthiophenyl)octane-1-one-2-imine, N-benzoyloxy-1-(4-phenylthiophenyl)-3-cyclopentylpropane-1-one-2-imine, N-acetoxy-1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazol-3-yl]ethane-1-imine, N-acetoxy-1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazol-3-yl]ethane-1-imine, N-acetoxy-1-[9-ethyl-6-{2-methyl-4-(3,3-dimethyl-2,4-dioxy)propane-1-imine, heterocyclopentylmethoxy)benzoyl}-9H-carbazole-3-yl]ethane-1-imine, N-acetoxy-1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazole-3-yl]-3-cyclopentylpropane-1-imine, N-benzoyloxy-1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazole-3-yl]-3-cyclopentylpropane-1-one-2-imine; compounds described in Japanese Unexamined Patent Publication No. 2011-132215, International Publication No. 2008 / 78678, International Publication No. 2008 / 78686, and International Publication No. 2012 / 132558, etc. Commercially available products such as Irgacure OXE01, OXE02 (all manufactured by BASF), and N-1919 (manufactured by ADEKA) can also be used.
[0361] Among them, the oxime compound having a partial structure represented by formula (d1) is preferably at least one selected from N-benzoyloxy-1-(4-phenylthiophenyl)butane-1-one-2-imine, N-benzoyloxy-1-(4-phenylthiophenyl)octane-1-one-2-imine and N-benzoyloxy-1-(4-phenylthiophenyl)-3-cyclopentylpropane-1-one-2-imine, and N-benzoyloxy-1-(4-phenylthiophenyl)octane-1-one-2-imine is more preferred.
[0362] Examples of the biimidazole compound include compounds represented by formula (d5).
[0363]
[0364] [In formula (d5), R E ~R J represents an aryl group having 6 to 10 carbon atoms which may have a substituent.]
[0365] Examples of the aryl group having 6 to 10 carbon atoms include phenyl, tolyl, xylyl, ethylphenyl and naphthyl, and preferably phenyl.
[0366] Examples of the substituent include a halogen atom and an alkoxy group having 1 to 4 carbon atoms. Examples of the halogen atom include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom, and preferably a chlorine atom. Examples of the alkoxy group having 1 to 4 carbon atoms include a methoxy group, an ethoxy group, a propoxy group, and a butoxy group, and preferably a methoxy group.
[0367] Examples of the biimidazole compound include 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetraphenylbiimidazole, 2,2'-bis(2,3-dichlorophenyl)-4,4',5,5'-tetraphenylbiimidazole (see, for example, Japanese Patent Application Laid-Open No. 06-75372 and Japanese Patent Application Laid-Open No. 06-75373), 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetraphenylbiimidazole, and 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetraphenylbiimidazole. Biimidazole compounds in which the phenyl groups at the 4,4',5,5'-positions are substituted with carbonyl alkoxy groups (for example, see Japanese Patent Publication No. 7-10913). Among them, compounds represented by the following formula or mixtures thereof are preferred.
[0368]
[0369] Examples of the triazine compound include 2,4-bis(trichloromethyl)-6-(4-methoxyphenyl)-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-(4-methoxynaphthyl)-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-piperonyl-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-(4-methoxyphenyl)-1,3,5-triazine, and 2,4-bis(trichloromethyl)-6-[ 2-(5-methylfuran-2-yl)vinyl]-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-[2-(furan-2-yl)vinyl]-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-[2-(4-diethylamino-2-methylphenyl)vinyl]-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-[2-(3,4-dimethoxyphenyl)vinyl]-1,3,5-triazine, etc. Among them, 2,4-bis(trichloromethyl)-6-piperonyl-1,3,5-triazine is preferred.
[0370] Examples of the acylphosphine compound include bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide and (2,4,6-trimethylbenzoyl)diphenylphosphine oxide.
[0371] Other examples of photopolymerization initiators other than the oxime compound (1) include, for example, benzoin compounds such as benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, and benzoin isobutyl ether; benzophenone compounds such as benzophenone, methyl o-benzoylbenzoate, 4-phenylbenzophenone, 4-benzoyl-4'-methyldiphenyl sulfide, 3,3',4,4'-tetrakis(tert-butylperoxycarbonyl)benzophenone, 2,4,6-trimethylbenzophenone, and 4,4'-bis(diethylamino)benzophenone; quinone compounds such as 9,10-phenanthrenequinone, 2-ethylanthraquinone, and camphorquinone; 10-butyl-2-chloroacridone, benzil, methyl benzoylformate, and titanocene compounds.
[0372] The other photopolymerization initiator other than the oxime compound (1) may be used alone or in combination of two or more. When the other photopolymerization initiator other than the oxime compound (1) is used together with the oxime compound (1), the other photopolymerization initiator may be an oxime compound other than the above-mentioned oxime compound (1), a biimidazole compound, a triazine compound, an acylphosphine compound, etc.
[0373] The content of the photopolymerization initiator (E) in the curable resin composition is preferably 0.1 to 300 parts by mass, and more preferably 0.1 to 200 parts by mass, relative to 100 parts by mass of the photopolymerizable compound (D). In addition, the content of the photopolymerization initiator (E) in the curable resin composition is preferably 0.1 to 30 parts by mass, and more preferably 1 to 20 parts by mass, relative to 100 parts by mass of the total amount of the resin (C) and the photopolymerizable compound (D). When the content of the photopolymerization initiator (E) is within the above range, there is a tendency for the curable resin composition to be highly sensitive and the exposure time to be shortened, and therefore there is a tendency for the productivity of the cured film to be improved.
[0374] From the viewpoint of improving the luminous intensity (brightness) of the cured film, the content of the oxime compound (1) in the photopolymerization initiator (E) is preferably 30% by mass to 100% by mass, more preferably 50% by mass to 100% by mass, further preferably 80% by mass to 100% by mass, further preferably 90% by mass to 100% by mass, particularly preferably 95% by mass to 100% by mass, and most preferably 100% by mass, relative to the total amount of the photopolymerization initiator (E).
[0375] [7] Photopolymerization initiator (E1)
[0376] The curable resin composition may further contain a photopolymerization initiation aid (E1) together with the photopolymerization initiator (E). The photopolymerization initiation aid (E1) is a compound or sensitizer for promoting the polymerization of the photopolymerizable compound (D) initiated by the photopolymerization initiator (E). Examples of the photopolymerization initiation aid (E1) include amine compounds, alkoxyanthracene compounds, thioxanthone compounds, and carboxylic acid compounds.
[0377] Examples of the amine compound include triethanolamine, methyldiethanolamine, triisopropanolamine, methyl 4-dimethylaminobenzoate, ethyl 4-dimethylaminobenzoate, isopentyl 4-dimethylaminobenzoate, 2-dimethylaminoethyl benzoate, 2-ethylhexyl 4-dimethylaminobenzoate, N,N-dimethyl-p-toluidine, 4,4'-bis(dimethylamino)benzophenone (commonly known as Michler's ketone), 4,4'-bis(diethylamino)benzophenone, and 4,4'-bis(ethylmethylamino)benzophenone. Among them, 4,4'-bis(diethylamino)benzophenone is preferred. Commercially available products such as EAB-F (manufactured by Hodogaya Chemical Industry Co., Ltd.) may also be used.
[0378] Examples of the alkoxyanthracene compound include 9,10-dimethoxyanthracene, 2-ethyl-9,10-dimethoxyanthracene, 9,10-diethoxyanthracene, 2-ethyl-9,10-diethoxyanthracene, 9,10-dibutoxyanthracene, and 2-ethyl-9,10-dibutoxyanthracene.
[0379] Examples of the thioxanthone compound include 2-isopropylthioxanthone, 4-isopropylthioxanthone, 2,4-diethylthioxanthone, 2,4-dichlorothioxanthone, and 1-chloro-4-propoxythioxanthone.
[0380] Examples of the carboxylic acid compound include phenylthioacetic acid, methylphenylthioacetic acid, ethylphenylthioacetic acid, methylethylphenylthioacetic acid, dimethylphenylthioacetic acid, methoxyphenylthioacetic acid, dimethoxyphenylthioacetic acid, chlorophenylthioacetic acid, dichlorophenylthioacetic acid, N-phenylglycine, phenoxyacetic acid, naphthylthioacetic acid, N-naphthylglycine, and naphthoxyacetic acid.
[0381] When the curable resin composition contains a photopolymerization initiator aid (E1), the content of the photopolymerization initiator aid (E1) in the curable resin composition is preferably 0.1 to 300 parts by mass, and more preferably 0.1 to 200 parts by mass, relative to 100 parts by mass of the photopolymerizable compound (D). In addition, the content of the photopolymerization initiator aid (E1) in the curable resin composition is preferably 0.1 to 30 parts by mass, and more preferably 1 to 20 parts by mass, relative to 100 parts by mass of the total amount of the resin (C) and the photopolymerizable compound (D). When the content of the photopolymerization initiator aid (E1) is within the above range, further high sensitivity of the curable resin composition can be achieved.
[0382] [8] Antioxidants (F)
[0383] The curable resin composition may further contain an antioxidant (F).
[0384] The antioxidant (F) is not particularly limited as long as it is an antioxidant generally used in industry, and phenolic antioxidants, phosphorus antioxidants, phosphorus / phenol composite antioxidants, sulfur antioxidants, etc. can be used. Two or more antioxidants (F) may be used in combination.
[0385] The phosphorus / phenol composite antioxidant may be a compound having one or more phosphorus atoms and a phenol structure in each molecule. Among them, the antioxidant (F) preferably contains a phosphorus / phenol composite antioxidant from the viewpoint of the developability of the curable resin composition and the luminescence intensity of the cured film.
[0386] Examples of the phenolic antioxidant include Irganox (registered trademark) 1010 (Irganox 1010: pentaerythritol tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate, manufactured by BASF Corporation), Irganox (registered trademark) 1076 (Irganox 1076: octadecyl-3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate, manufactured by BASF Corporation), Irganox (registered trademark) 1330 (Irganox 1330: 3,3',3",5,5',5"-hexa-tert-butyl-a,a',a"-(mesitylene-2,4,6-triyl)tri-p-cresol, manufactured by BASF Corporation), and Irganox (registered trademark) 3114 (Irganox 3114: 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione, manufactured by BASF Corporation), Irganox (registered trademark) 3790 (Irganox 3790: 1,3,5-tris((4-tert-butyl-3-hydroxy-2,6-xylyl)methyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione, manufactured by BASF Corporation), Irganox (registered trademark) 1035 (Irganox 1035: thiodiethylene bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate], manufactured by BASF Corporation), Irganox (registered trademark) 1135 (Irganox 1135: 3,5-bis(1,1-dimethylethyl)-4-hydroxy-C7-C9 side chain alkyl ester of phenylpropionic acid, manufactured by BASF Corporation), Irganox (registered trademark) 1520L (Irganox 1520L: 4,6-bis(octylthiomethyl)-o-cresol, manufactured by BASF Corporation), Irganox (registered trademark) 3125 (Irganox 3125, manufactured by BASF Corporation), Irganox (registered trademark) 565 (Irganox 565: 2,4-bis(n-octylthio)-6-(4-hydroxy-3',5'-di-tert-butylanilino)-1,3,5-triazine, manufactured by BASF Corporation), Adekastab (registered trademark) AO-80 (Adekastab AO-80: 3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy)-1,1-dimethylethyl)-2,4,8,10-tetraoxaspiro(5,5) Undecane (manufactured by ADEKA Co., Ltd.), Sumilizer (registered trademark) BHT, Sumilizer (registered trademark) GA-80, Sumilizer (registered trademark) GS (all manufactured by Sumitomo Chemical Co., Ltd.), Cyanox (registered trademark) 1790 (Cyanox 1790, manufactured by Sitech Co., Ltd.), and vitamin E (manufactured by Eisai Co., Ltd.), etc.
[0387] Examples of the phosphorus-based antioxidant include Irgafos (registered trademark) 168 (Irgafos 168: tris(2,4-di-tert-butylphenyl)phosphite, manufactured by BASF Corporation), Irgafos (registered trademark) 12 (Irgafos 12: tris[2-[[2,4,8,10-tetra-tert-butyldibenzo[d,f][1,3,2]dioxaphosphin-6-yl]oxy]ethyl]amine, manufactured by BASF Corporation), Irgafos (registered trademark) 38 (Irgafos 38: bis(2,4-bis(1,1-dimethylethyl)-6-methylphenyl)ethyl phosphite, manufactured by BASF Corporation), Adekastab (registered trademark) 329K, Adekastab (registered trademark) PEP36, Adekastab (registered trademark) PEP-8 (all manufactured by ADEKA Corporation), and Sandstab P-EPQ (manufactured by Clariant), Weston (registered trademark) 618, Weston (registered trademark) 619G (all manufactured by GE), Ultranox 626 (manufactured by GE), etc.
[0388] Examples of phosphorus / phenol composite antioxidants include Sumilizer (registered trademark) GP (6-[3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propoxy]-2,4,8,10-tetra-tert-butyldibenzo[d,f][1.3.2]dibenzoylmethane) and Sumilizer (registered trademark) GP (6-[3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propoxy]-2,4,8,10-tetra-tert-butyldibenzo[d,f][1.3.2]dibenzoylmethane). Phosphate) (manufactured by Sumitomo Chemical Co., Ltd.) etc.
[0389] Examples of the sulfur-based antioxidant include dialkyl thiodipropionate compounds such as dilauryl thiodipropionate, dimyristyl thiodipropionate, and distearyl thiodipropionate, and β-alkylmercaptopropionate compounds of polyhydric alcohols such as tetrakis[methylene(3-dodecylthio)propionate]methane.
[0390] The content of the antioxidant (F) in the curable resin composition is, for example, 1 to 50 parts by mass, relative to 100 parts by mass of the resin (C), preferably 5 to 40 parts by mass, more preferably 7 to 30 parts by mass, and further preferably 11 to 25 parts by mass from the viewpoint of the luminescence amount and heat resistance of the cured film.
[0391] [9]Solvent (G)
[0392] The solvent (G) is not particularly limited as long as it dissolves the resin (C), the photopolymerizable compound (D) and the photopolymerization initiator (E), and a solvent commonly used in this field can be used. For example, ester solvents (solvents containing -COO- and not containing -O- in the molecule), ether solvents (solvents containing -O- and not containing -COO- in the molecule), ether ester solvents (solvents containing -COO- and -O- in the molecule), ketone solvents (solvents containing -CO- and not containing -COO- in the molecule), alcohol solvents (solvents containing OH and not containing -O-, -CO- and -COO- in the molecule), aromatic hydrocarbon solvents, amide solvents, dimethyl sulfoxide, and the like can be cited.
[0393] Examples of the ester solvent include methyl lactate, ethyl lactate, n-butyl lactate, methyl 2-hydroxyisobutyrate, ethyl acetate, n-butyl acetate, isobutyl acetate, n-amyl formate, isoamyl acetate, n-butyl propionate, isopropyl butyrate, ethyl butyrate, n-butyl butyrate, methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, cyclohexanol acetate, and γ-butyrolactone.
[0394] Examples of the ether solvent include ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, ethylene glycol monobutyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, propylene glycol monobutyl ether, 3-methoxy-1-butanol, 3-methoxy-3-methylbutanol, tetrahydrofuran, tetrahydropyran, 1,4-dihydrofu ... Alkane, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol methyl ethyl ether, diethylene glycol dipropyl ether, diethylene glycol dibutyl ether, anisole, phenethyl ether and methyl anisole, etc.
[0395] Examples of the ether ester solvent include methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate, ethyl ethoxyacetate, methyl 3-methoxypropionate, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, methyl 2-methoxypropionate, ethyl 2-methoxypropionate, propyl 2-methoxypropionate, methyl 2-ethoxypropionate, ethyl 2-ethoxypropionate, methyl 2-methoxy-2-methylpropionate, ethyl 2-ethoxy-2-methylpropionate, 3-methoxybutyl acetate, 3-methyl-3-methoxybutyl acetate, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, propylene glycol monopropyl ether acetate, ethylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether acetate, diethylene glycol monoethyl ether acetate, and diethylene glycol monobutyl ether acetate.
[0396] Examples of the ketone solvent include 4-hydroxy-4-methyl-2-pentanone, acetone, 2-butanone, 2-heptanone, 3-heptanone, 4-heptanone, 4-methyl-2-pentanone, cyclopentanone, cyclohexanone, and isophorone.
[0397] Examples of the alcohol solvent include methanol, ethanol, propanol, butanol, hexanol, cyclohexanol, ethylene glycol, propylene glycol, and glycerin.
[0398] Examples of the aromatic hydrocarbon solvent include benzene, toluene, xylene, and mesitylene.
[0399] Examples of the amide solvent include N,N-dimethylformamide, N,N-dimethylacetamide, and N-methylpyrrolidone.
[0400] The solvent (G) is preferably propylene glycol monomethyl ether acetate, ethyl lactate, propylene glycol monomethyl ether, ethyl 3-ethoxypropionate, ethylene glycol monomethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, 4-hydroxy-4-methyl-2-pentanone or toluene, or a mixture of two or more thereof.
[0401] The solvent (G) is a component other than the solid component. For example, the solvent contained in the quantum dots (A) and the resin (C) is also included in the solvent (G).
[0402] The content of the solvent (G) in the curable resin composition is the ratio of the total mass of all solvents contained in the composition to the total amount of the composition, and is, for example, 40% to 95% by mass, preferably 55% to 90% by mass, relative to the total amount of the curable resin composition. In other words, the solid content of the curable resin composition is preferably 5% to 60% by mass, more preferably 10% to 45% by mass. When the content of the solvent (G) is within the above range, there is a tendency that the flatness of the composition layer during coating becomes better and a cured film of an appropriate film thickness is easily formed.
[0403]
[10] Leveling agent (H)
[0404] The curable resin composition may further contain a leveling agent (H).
[0405] As the leveling agent (H), silicone surfactants, fluorine-based surfactants and silicone surfactants having fluorine atoms can be cited. They may have polymerizable groups in the side chains. From the viewpoint of the developability of the curable resin composition and the luminous intensity of the cured film, the leveling agent (H) is preferably a fluorine-based surfactant.
[0406] Examples of the silicone surfactant include surfactants having a siloxane bond in the molecule. Specifically, examples include Toray Silicone DC3PA, Toray Silicone SH7PA, Toray Silicone DC11PA, Toray Silicone SH21PA, Toray Silicone SH28PA, Toray Silicone SH29PA, Toray Silicone SH30PA, Toray Silicone SH8400 (trade name: manufactured by Dow Corning Toray Co., Ltd.), KP321, KP322, KP323, KP324, KP326, KP340, KP341 (Shin-Etsu Chemical Co., Ltd.), TSF400, TSF401, TSF410, TSF4300, TSF4440, TSF4445, TSF4446, TSF4452, and TSF4460 (manufactured by Momentive Performance Materials Japan Co., Ltd.).
[0407] Examples of the fluorine-based surfactant include surfactants having a fluorine carbon chain in the molecule. Specifically, examples include FLUORAD (registered trademark) FC430, FLUORAD FC431 (manufactured by Sumitomo 3M Co., Ltd.), MEGAFAC (registered trademark) F142D, MEGAFAC F171, MEGAFAC F172, MEGAFAC F173, MEGAFAC F177, MEGAFAC F183, MEGAFAC F554, MEGAFAC F575, MEGAFAC R30, MEGAFAC RS-718-K (manufactured by DIC Corporation), F-top (registered trademark) EF301, F-top EF303, F-top EF351, F-top EF352 (manufactured by Mitsubishi Materials Electronic Chemicals Co., Ltd.), Surflon (registered trademark) S381, Surflon S382, Surflon SC101, Surflon SC105 (manufactured by Asahi Glass Co., Ltd.) and E5844 (manufactured by Daikin Fine Chemicals Laboratories, Ltd.), etc.
[0408] Examples of the organosilicon-based surfactant having a fluorine atom include surfactants having a siloxane bond and a fluorocarbon chain in the molecule, and more specifically, MEGAFAC (registered trademark) R08, MEGAFAC BL20, MEGAFAC F475, MEGAFAC F477, and MEGAFAC F443 (manufactured by DIC Corporation).
[0409] When the curable resin composition contains a leveling agent (H), the content of the leveling agent (H) in the curable resin composition is, for example, 0.001% by mass to 1.0% by mass, preferably 0.005% by mass to 0.75% by mass, more preferably 0.01% by mass to 0.5% by mass, and further preferably 0.05% by mass to 0.5% by mass, relative to the total amount of the curable resin composition. When the content of the leveling agent (H) is within the above range, the flatness of the cured film can be further improved.
[0410]
[11] Light scattering agent (I)
[0411] The curable resin composition may further contain a light scattering agent (I). Examples of the light scattering agent (I) include particles of metal or metal oxide, glass particles, and the like.
[0412] Examples of the metal oxide include TiO2, SiO2, BaTiO3, and ZnO. The particle size of the light scattering agent (I) is, for example, about 0.03 μm to 20 μm, preferably 0.05 μm to 1 μm, and more preferably 0.05 μm to 0.5 μm.
[0413] As the light scattering agent (I), a dispersion obtained by preliminarily dispersing the light scattering agent in a part or all of the solvent (G) using a dispersant can be used. As the dispersant, a commercially available product can be used.
[0414] Examples of commercially available products include:
[0415] BYK-Chemie Japan's DISPERBYK-101, 102, 103, 106, 107, 108, 109, 110, 111, 116, 118, 130, 140, 154, 161, 162, 163, 164, 165, 166, 170, 171, 174, 180, 181, 182, 183, 184, 185, 190, 192, 2000, 2001, 2020, 2025, 2050, 2070, 2095, 2150, 2155; ANTI-TERRA-U, U100, 203, 204, 250; BYK- P104, P104S, P105, 220S, 6919; BYK-LPN6919, 21116; LACTIMON, LACTIMON-WS; Bykumen, etc.;
[0416] SOLSPERSE made by Japan Lubrizol Corporation: 3000, 9000, 13000, 13240, 13650, 13940, 16000, 17000, 18000, 20000, 21000, 24000, 26000, 27000, 28000, 31845, 32000, 32500, 32550, 33500, 32600, 34750, 35100, 36600, 38500, 41000, 41090, 53095, 55000, 76500, etc.;
[0417] EFKA-46, 47, 48, 452, 4008, 4009, 4010, 4015, 4020, 4047, 4050, 4055, 4060, 4080, 4400, 4401, 4402, 4403, 4406, 4408, 4300, 4310, 4320, 4330, 4340, 450, 451, 453, 4540, 4550, 4560, 4800, 5010, 5065, 5066, 5070, 7500, 7554, 1101, 120, 150, 1501, 1502, 1503, etc. manufactured by BASF;
[0418] Ajisper PA111, PB711, PB821, PB822, PB824, etc. manufactured by Ajinomoto Fine Chemicals Co., Ltd.
[0419] The content of the light scattering agent (I) in the curable resin composition is, for example, 0.001% by mass to 50% by mass, preferably 1% by mass to 30% by mass, and more preferably 2% by mass to 10% by mass, relative to the total amount of solid content of the curable resin composition, from the viewpoint of the developability of the curable resin composition and the luminous intensity of the cured film.
[0420] In addition, the curable resin composition may further contain additives known in the technical field such as a polymerization inhibitor, a filler, other polymer compounds, an adhesion promoter, a light stabilizer, and a chain transfer agent, as needed.
[0421] <Method for producing curable resin composition>
[0422] The method for producing a curable resin composition may include the step of mixing quantum dots (A), compound (B-1), resin (C), photopolymerizable compound (D), photopolymerization initiator (E), and other components used as needed. The method for producing a curable resin composition may further include the step of preparing resin (C).
[0423] <Cured film>
[0424] The cured film of the present invention (hereinafter, also referred to as "cured film") can be obtained by applying the curable resin composition of the present invention to a substrate and curing it under the action of light and further heat as needed. The cured film contains quantum dots (A) and resin (C) contained in the curable resin composition. In addition, the cured film contains a cured reaction product of a photopolymerizable compound (D) and a photopolymerization initiator (E) contained in the curable resin composition. The cured reaction product is a substance containing a structure brought about by the structure of the photopolymerizable compound (D) and the photopolymerization initiator (E). The structure brought about by the structure of the photopolymerizable compound (D) and the photopolymerization initiator (E) refers to, for example, a skeleton structure or a part thereof other than the curing reaction site of the photopolymerizable compound (D) and the photopolymerization initiator (E). In addition, the cured film contains a substance containing a structure brought about by the compound (B-1) or its structure contained in the curable resin composition.
[0425] The cured film may be formed on the entire surface of the substrate or may be formed on a portion of the substrate (ie, a cured pattern). As described above, the cured pattern is one aspect of the cured film and refers to a cured film formed in a pattern.
[0426] As a method for forming a cured film on a part of the above-mentioned substrate, photolithography, inkjet method, printing method, etc. can be cited. Among them, photolithography is preferred. Photolithography is a method in which a curable resin composition is applied to a substrate and dried as needed to form a composition layer, and the composition layer is exposed through a photomask and developed.
[0427] Examples of a method for forming a cured film on the entire surface of a substrate include a method of applying a curable resin composition to a substrate and drying it as necessary to form a composition layer, and heating and / or exposing the entire surface of the composition layer to light.
[0428] Examples of the substrate include glass plates such as quartz glass, borosilicate glass, aluminosilicate glass, soda-lime glass with a surface coated with silicon dioxide, resin plates such as polycarbonate, polymethyl methacrylate, polyethylene terephthalate, silicon, and substrates having aluminum, silver, silver / copper / palladium alloy thin films formed on the above substrates.
[0429] The formation of the cured pattern by photolithography can be performed using a known or customary apparatus and conditions. For example, it can be produced as follows.
[0430] First, a curable resin composition is applied onto a substrate and dried by heating (pre-baking) and / or drying under reduced pressure to remove volatile components such as a solvent to obtain a composition layer. Examples of the coating method include spin coating, slit coating, and slit spin coating.
[0431] The temperature during heat drying is preferably 30° C. to 120° C., more preferably 50° C. to 110° C. The heating time is preferably 10 seconds to 60 minutes, more preferably 30 seconds to 30 minutes.
[0432] When the reduced pressure drying is performed, it is preferably performed at a pressure of 50 Pa to 150 Pa and a temperature range of 20°C to 25°C.
[0433] The thickness of the composition layer is not particularly limited and may be appropriately selected according to the thickness of the target cured pattern, and is, for example, 1 μm to 20 μm, preferably 1.5 μm to 18 μm, more preferably 2 μm to 14 μm, and further preferably 2 μm to 12 μm.
[0434] Next, the composition layer is exposed through a photomask for forming a target cured pattern. The shape of the pattern on the photomask is not particularly limited.
[0435] As the light source used in the exposure, a light source generating light with a wavelength of 250 to 450 nm is preferred. For example, light near 436 nm, near 408 nm, or near 365 nm can be selectively extracted from the light of this wavelength using a bandpass filter according to the absorption wavelength of the photopolymerization initiator (E). Specific examples of the light source include mercury lamps, light emitting diodes, metal halide lamps, and halogen lamps.
[0436] In order to uniformly irradiate the entire exposure surface with parallel light and accurately align the photomask with the substrate on which the composition layer is formed, it is preferred to use an exposure device such as a mask aligner and a stepper. The composition layer after exposure is cured by polymerization of the photopolymerizable compound (D) etc. contained in the composition layer.
[0437] The exposed composition layer is brought into contact with a developer for development, whereby the unexposed portion of the composition layer is dissolved in the developer and removed to obtain a cured pattern. As the developer, for example, aqueous solutions of alkaline compounds such as potassium hydroxide, sodium bicarbonate, sodium carbonate, and tetramethylammonium hydroxide, and organic solvents can be cited. The concentration of the alkaline compound in the aqueous solution is preferably 0.01% to 10% by mass, more preferably 0.03% to 5% by mass. As the organic solvent, the same solvent as the above-mentioned solvent (G) can be cited. The developer may contain a surfactant.
[0438] The developing method may be any of a spin immersion method, a dipping method, a spray method, etc. Furthermore, the substrate may be tilted at any angle during the developing process.
[0439] It is preferred to further heat (post-bake) the cured pattern obtained by development. The heating temperature is preferably 150 to 250° C., more preferably 160 to 235° C. The heating time is preferably 1 to 120 minutes, more preferably 10 to 60 minutes. By heating after development, the unreacted photopolymerizable compound (D) and the like contained in the cured pattern can be polymerized, thereby obtaining a cured pattern with better chemical resistance. In the case of no development, it is also preferred to further heat (post-bake) the composition layer after exposure.
[0440] By irradiating the cured film with ultraviolet light or visible light, the cured film can emit light of a wavelength different from that of the irradiated light. The wavelength of the emitted light can be selected by selecting the composition and particle size of the quantum dots (A) in the curable resin composition used when forming the cured film. The cured film has the function of converting the wavelength of the irradiated light as described above, and can therefore be used as a color conversion layer (wavelength conversion film) of a display device.
[0441] The cured film can exhibit good luminous intensity. The luminous intensity (brightness) of the cured film measured by the measuring method in the Examples column described later is preferably 1100 μW or more, more preferably 1200 μW or more, further preferably 1300 μW or more, and further preferably 1350 μW or more.
[0442] The luminous intensity of the cured film is preferably 1100 μW or more, more preferably 1200 μW or more, further preferably 1300 μW or more, and further preferably 1350 μW or more, for example, when the content of the quantum dots (A) in the curable resin composition is 21.5% by mass.
[0443] The thickness of the cured film is 1 μm to 20 μm, preferably 1.5 μm to 18 μm, more preferably 2 μm to 14 μm, and further preferably 2 μm to 12 μm.
[0444] The curable resin composition of the present invention is useful as a color conversion layer of a display device, particularly a liquid crystal display device, an organic EL display device, or an inorganic EL display device, because the development speed is sufficiently fast and a cured film with good luminous intensity can be formed. As such a display device, for example, display devices described in Japanese Patent Application Publication No. 2006-309219, Japanese Patent Application Publication No. 2006-310303, Japanese Patent Application Publication No. 2013-15812, Japanese Patent Application Publication No. 2009-251129, Japanese Patent Application Publication No. 2014-2363, etc. can be cited.
[0445] The display device at least comprises a light source and the above-mentioned cured film. The display device is not particularly limited, and may further comprise a light absorbing layer, a light reflecting component (reflecting film, etc.), a diffusion film, a brightness enhancement part, a prism sheet, a light guide plate, a dielectric material layer between elements, and other layers.
[0446] The light absorbing layer is a layer having wavelength selectivity that transmits light in a specific wavelength range and absorbs light in other wavelength ranges. The light absorbing layer is usually a layer containing a colorant such as a dye or a pigment, and can be disposed on the above-mentioned cured film. As the light absorbing layer, a light absorbing layer that is conventionally known as a color filter can be used.
[0447] The light reflecting component is a component used to reflect the light from the light source toward the above-mentioned cured film, and may be a reflector, a film of reflective particles, a reflective metal film, or a reflector, etc. The diffusion film is a film used to diffuse the light from the light source or the light emitted from the cured film, and may be an amplifying diffusion film, etc. The brightness enhancement unit is a component used to reflect and return a part of the light in the direction of light transmission.
[0448] The prism sheet typically has a substrate portion and a prism portion. It should be noted that the substrate portion can be omitted according to the adjacent components. The prism sheet can be attached to the adjacent components via any appropriate bonding layer (for example, an adhesive layer, a bonding agent layer). The prism sheet is composed of a plurality of unit prisms protruding on the side opposite to the visual side (back side) arranged in parallel. By arranging the convex portion of the prism sheet toward the back side, the light passing through the prism sheet is easily focused. In addition, if the convex portion of the prism sheet is arranged toward the back side, the light that is not incident on the prism sheet and is reflected is less than when the convex portion is arranged toward the visual side, and a display device with higher brightness can be obtained.
[0449] Any appropriate light guide plate may be used as the light guide plate. For example, a light guide plate having a lens pattern formed on the back side or a prism shape formed on the back side and / or the viewing side may be used to deflect light from the lateral direction in the thickness direction.
[0450] The display device may include a layer composed of one or more dielectric materials on the optical path between adjacent elements (layers). The one or more dielectric materials include, for example, vacuum, air, gas, optical material, adhesive, optical adhesive, glass, polymer, solid, liquid, gel, curing material, optical adhesive material, refractive index matching or refractive index mismatching material, refractive index gradient material, coating or anti-coating material, spacer, silica gel, brightness enhancement material, scattering or diffusion material, reflection or anti-reflection material, wavelength selective material, wavelength selective anti-reflection material or other suitable media known in the technical field, but are not limited thereto and may include any suitable material.
[0451] As a specific example of the display device, for example, a display device equipped with a wavelength conversion material for an EL display or a liquid crystal display can be cited. Specifically, a display device in which the above-mentioned cured film as a wavelength conversion layer is arranged between a blue light source (A) and a light guide plate so as to be along the end face (side face) of the light guide plate, and a backlight (on-edge type backlight) that emits white light is constituted, and a light absorption layer is disposed on the light guide plate side; a display device in which the above-mentioned cured film as a wavelength conversion layer is arranged on a light guide plate, and a backlight (surface mount type backlight) that emits light irradiated from a blue light source arranged on the end face (side face) of the light guide plate to the wavelength conversion layer is constituted, and a light absorption layer is disposed on the wavelength conversion layer; a display device in which the above-mentioned cured film is arranged near the light emitting part of the blue light source as a wavelength conversion layer, and a backlight (on-chip type backlight) that emits the irradiated light is constituted as white light is constituted, and a light absorption layer is disposed on the wavelength conversion layer, etc.
[0452] Example
[0453] Hereinafter, the present invention will be described in more detail with reference to Examples. "%" and "parts" in the Examples are by mass % and by mass parts unless otherwise specified.
[0454] 〔Measurement of luminous intensity〕
[0455] The curable resin composition was applied to a 5 cm square glass substrate (EAGLE 2000; manufactured by CORNING) by spin coating in a film thickness of 10 μm, and then pre-baked at 100° C. for 3 minutes to form a curable composition layer. The substrate with the curable composition layer was exposed to 80 mJ / cm in an air atmosphere using an exposure machine (TME-150RSK; manufactured by TOPCON). 2 The substrate was irradiated with light at an exposure amount of 100 nm (365 nm reference), and after development, post-baking was performed at 180° C. for 60 minutes to obtain a substrate having a cured film.
[0456] A narrow-angle induction backlight (OPF series; manufactured by OPTEX Fa) equipped with an LED lamp with a light emission wavelength of 444 nm and a scratch-resistant cover was prepared as a backlight. The backlight was placed with the scratch-resistant cover facing upward, and an optical fiber for detecting light emission connected to the spectrometer described below was set at a height of 4 cm from the surface of the scratch-resistant cover. A glass substrate (EAGLE 2000; manufactured by CORNING) was arranged on the surface of the scratch-resistant cover of the backlight as a reference. In this state, the backlight was turned on, and the light intensity of the backlight was adjusted so that the total radiant flux (μW) of the backlight passing through the reference glass substrate (EAGLE 2000; manufactured by CORNING) became 5000 μW.
[0457] Next, the substrate with the cured film prepared above was placed on the surface of the glass substrate. In this state, the backlight was turned on, and the luminous intensity (unit: μW) of the light emitted from the cured film was measured in the form of the cumulative radiant flux in the wavelength range of 485nm to 780nm. The luminous intensity was measured using a spectrometer (manufactured by Ocean Optics).
[0458] [Determination of development speed]
[0459] The curable resin composition was applied to a 5 cm square glass substrate (EAGLE 2000; manufactured by CORNING) by spin coating in a film thickness of 10 μm, and then pre-baked at 100° C. for 3 minutes to form a curable resin composition layer. The substrate having the curable resin composition layer was immersed in a developer (aqueous solution of 0.048% potassium hydroxide) and developed. The time (seconds) for complete removal of the curable resin composition layer was measured to evaluate the development speed.
[0460] 〔Determination of residual film rate〕
[0461] As a solvent resistance test, the following test was performed, and the residual film ratio was measured to evaluate the solvent resistance.
[0462] The curable resin composition was applied to a 5 cm square glass substrate (EAGLE 2000; manufactured by CORNING) by spin coating in a film thickness of 10 μm, and then pre-baked at 100° C. for 3 minutes to form a curable composition layer. The substrate with the curable composition layer formed was exposed to light at 80 mJ / cm in an air atmosphere using an exposure machine (TME-150RSK; manufactured by TOPCON). 2 The substrate was irradiated with light at an exposure amount of 100 nm (365 nm reference), and after development, post-baking was performed at 180° C. for 60 minutes to obtain a substrate having a cured film.
[0463] Next, the substrate having the cured film was immersed in acetone at 25° C. for 5 hours, and the residual film ratio was measured according to the following formula. The film thickness of the cured film was measured by measuring the height difference of scratches on the surface of the cured film using a probe step profiler (DektakXT, manufactured by Bluker Corporation).
[0464] Residual film rate (%) = 100 × (thickness of cured film after test) / (thickness of cured film before test)
[0465] 〔Weight average molecular weight〕
[0466] The weight average molecular weight (Mw) of the resin (C-1) was measured by a GPC method under the following conditions.
[0467] Device: K2479 (manufactured by Shimadzu Corporation)
[0468] Column: SHIMADZU Shim-pack GPC-80M
[0469] Column temperature: 40°C
[0470] Solvent: Tetrahydrofuran
[0471] Flow rate: 1.0mL / min
[0472] Detector: RI
[0473] Calibration standard substances: TSK STANDARD POLYSTYRENE F-40, F-4, F-288, A-2500, A-500 (manufactured by Tosoh Corporation)
[0474] 〔Acid value〕
[0475] 3 g of the resin (C-1) solution was accurately weighed and dissolved in a mixed solvent of 90 g of acetone and 10 g of water. A 0.1-normal aqueous KOH solution was used as a titrant. The acid value of the resin (C-1) solution was measured using an automatic titrator (manufactured by Hiranuma Industries, trade name: COM-555). The acid value (AV) per 1 g of solid content was calculated from the acid value of the solution and the solid content of the solution.
[0476] 〔Solid content〕
[0477] About 1 g of the resin (C-1) solution was weighed in an aluminum cup, dried at 180° C. for 1 hour, and then the mass was measured. The solid content (mass %) of the resin (C-1) solution was calculated from the mass loss.
[0478] (Production Example 1: Preparation of a Dispersion Liquid of Quantum Dots (A-1))
[0479] A toluene dispersion of InP / ZnSeS quantum dots coordinated with oleic acid as a ligand was prepared. The dispersion was distilled under reduced pressure to remove toluene. 70 parts of cyclohexyl acetate was added to 30 parts of the solid content to obtain a dispersion of quantum dots (A-1) (solid content 30%).
[0480] (Production Example 2: Preparation of a dispersion of a light scattering agent (I-1))
[0481] To 70 parts of titanium oxide nanoparticles, 3 parts of DISPERBYK 21116 (manufactured by BYK-Chemie Japan) in terms of solid content were added, and propylene glycol monomethyl ether acetate (hereinafter referred to as "PGMEA") was added to make the total amount 100 parts, and then stirred with a paint shaker until fully dispersed to obtain a dispersion of the scattering agent (I-1) (solid content 73%).
[0482] (Production Example 3: Preparation of Resin (C-1) Solution)
[0483] 110 parts of PGMEA were added to a flask equipped with a stirrer, a reflux cooling tube with a thermometer, a dropping funnel, and a nitrogen inlet tube, and the mixture was stirred while nitrogen substitution was performed, and the temperature was raised to 80° C. 25 parts of dicyclopentanyl methacrylate, 26 parts of methyl methacrylate, 16 parts of methacrylic acid, and 11 parts of 2,2'-azobis(2,4-dimethylvaleronitrile) were dissolved in 110 parts of PGMEA, and the resulting solution was dropped from the dropping funnel into the flask, and stirred at 80° C. for 3 hours.
[0484] Next, 16 parts of glycidyl methacrylate, 0.4 parts of 2,2'-methylenebis(4-methyl-6-tert-butylphenol), and 0.8 parts of triphenylphosphine were added to the flask, heated to 110°C, and stirred for 8 hours to react the carboxylic acid in the polymer with the epoxy group to introduce a polymerizable unsaturated bond. Next, 17 parts of 1,2,3,6-tetrahydrophthalic anhydride were added and the reaction was continued for 3 hours to introduce a carboxylic acid group into the side chain. The reaction solution was cooled to room temperature to obtain a resin (C-1) solution.
[0485] The weight average molecular weight of the resin (C-1) in terms of standard polystyrene was 7600, the molecular weight distribution was 2.1, the acid value was 100 mgKOH / g, and the solid content in the resin (C-1) solution was 40% by mass.
[0486] <Example 1>
[0487] (1) Preparation of quantum dot dispersion containing compound (B-1) and compound (B-3) A predetermined amount of compound (B-1) was added to the dispersion of quantum dots (A-1) obtained in Production Example 1, and the mixture was stirred at 80° C. for 2 hours to obtain a quantum dot dispersion containing compound (B-1) and compound (B-3).
[0488] Compound (B-3) refers to oleic acid contained in the InP / ZnSeS quantum dots coordinated with oleic acid used in Production Example 1 above.
[0489] (2) Preparation of curable resin composition
[0490] The quantum dot dispersion containing the compound (B-1) and the compound (B-3) obtained in the above (1), the dispersion of the light scattering agent (I-1) obtained in Production Example 2, the resin (C-1) solution obtained in Production Example 3, and other components shown in Table 1 were mixed in predetermined amounts to prepare a curable resin composition.
[0491] The content of each component in the curable resin composition calculated from the added amount is shown in Table 1. In Table 1, the components other than the solvent (G) are the contents converted to solid content (unit: parts by mass). The unit of the content of the solvent (G) is parts by mass. For example, quantum dots (A-1) are formulated in the form of a dispersion of quantum dots (A-1) in the preparation of the curable resin composition, but the content shown in Table 1 is the amount of the quantum dots (A-1) itself contained in the solution. The solvent (G) in Table 1 includes the solvent contained in the dispersion and solution used in the preparation of the curable resin composition.
[0492] The content of the compound (B-3) in the curable resin composition shown in Table 1 was calculated based on the value of the concentration of the compound (B-3) in the dispersion of the quantum dots (A-1) obtained in Production Example 1 measured by the method [a] below.
[0493] <Examples 2 to 4>
[0494] (1) Preparation of quantum dot dispersion containing compounds (B-1) to (B-3)
[0495] A predetermined amount of compound (B-2) was added to the dispersion of quantum dots (A-1) obtained in Preparation Example 1, and the mixture was stirred at 80°C for 12 hours. The dispersion was then added dropwise to hexane for precipitation. The precipitate was recovered and redispersed in cyclohexyl acetate to obtain a quantum dot dispersion X (solid content 30%) containing compound (B-2) from which a portion of compound (B-3) was removed.
[0496] A predetermined amount of compound (B-1) was added to the quantum dot dispersion X, and the mixture was stirred at 80° C. for 2 hours to obtain a quantum dot dispersion Y containing compounds (B-1) to (B-3).
[0497] (2) Preparation of curable resin composition
[0498] The quantum dot dispersion Y containing compounds (B-1) to (B-3) obtained in the above (1), the dispersion of the light scattering agent (I-1) obtained in Production Example 2, the resin (C-1) solution obtained in Production Example 3, and other components shown in Table 1 were mixed in predetermined amounts to prepare a curable resin composition.
[0499] Table 1 shows the contents of the components in the curable resin composition obtained from the added amounts.
[0500] For each content of compound (B-2) and compound (B-3) in the curable resin composition shown in Table 1, the total concentration of compound (B-2) and compound (B-3) in quantum dot dispersion liquid X was measured according to the following method, and the content ratio of compound (B-2) to compound (B-3) in quantum dot dispersion liquid X was measured according to the following method, and calculation was performed based on these values.
[0501] [a] Determination of the total concentration of compound (B-2) and compound (B-3)
[0502] After the quantum dot dispersion X was vacuum dried at 150°C to remove the solvent, the weight change of the remaining solid content was measured at a temperature increase rate of 5°C / min at 50°C to 550°C using a thermogravimetric analyzer "TGDTA6200". The weight change from 50°C to 500°C was taken as the total weight of compound (B-2) and compound (B-3), and the total concentration of compound (B-2) and compound (B-3) in the quantum dot dispersion X was calculated.
[0503] [b] Determination of the content ratio of compound (B-2) to compound (B-3)
[0504] The quantum dot dispersion liquid X was subjected to GC / MS analysis using a GC / MS analyzer "7890B / 5977A (manufactured by Agilent)". The measurement conditions are as follows.
[0505] Measurement sample: A solution prepared by diluting 1 part by mass of the quantum dot dispersion X with 3 parts by mass of acetone
[0506] Column: DB-5 (0.25mm×30m, membrane thickness: 250mm)
[0507] Carrier gas: He, 1 mL / min
[0508] Column temperature: 50°C (5 minutes) → 10°C / min → 320°C (8 minutes)
[0509] Detector: MS
[0510] Inlet temperature: 200°C
[0511] AuX temperature: 250℃
[0512] Split ratio: 40:1
[0513] Injection volume: 1 μL
[0514] Ion source: EI, m / z 10-600
[0515] A calibration curve was prepared using PGMEA as a standard substance, and based on the calibration curve, the content ratio of the compound (B-2) to the compound (B-3) in the quantum dot dispersion liquid X was determined by GC / MS analysis.
[0516] <Example 5>
[0517] A curable resin composition was prepared in the same manner as in Example 1, except that a photopolymerization initiator (E-2) was used instead of the photopolymerization initiator (E-1).
[0518] <Example 6>
[0519] A curable resin composition was prepared in the same manner as in Example 5, except that the compound described in Table 1 was used in the amount described in Table 1 as the photopolymerizable compound (D).
[0520] <Comparative Example 1>
[0521] A curable resin composition was prepared in the same manner as in Example 5 except that the quantum dot dispersion containing the compound (B-1) and the compound (B-3) was replaced with the quantum dot dispersion (A-1) and the amount of the resin (C-1) solution added was changed.
[0522] The obtained curable resin composition was measured and evaluated for luminous intensity (brightness), developing speed, and residual film ratio as described above.
[0523] [Table 1]
[0524]
[0525] The details of the abbreviations of the components shown in Table 1 are as follows.
[0526] [1] Compound (B-1): 3-mercaptopropionic acid (manufactured by Tokyo Chemical Industry Co., Ltd., solid content 100%)
[0527] [2] Compound (B-2): 2-[2-(2-methoxyethoxy)ethoxy]acetic acid (manufactured by Sigma-Aldrich, solid content 100%)
[0528] [3] Compound (B-3): Oleic acid
[0529] [4] Photopolymerizable compound (D-1): M-510 (polyacid-modified acrylate, manufactured by Toagosei Co., Ltd., solid content 100%)
[0530] [5] Photopolymerizable compound (D-2): A-9550 (dipentaerythritol polyacrylate, manufactured by Shin-Nakamura Chemical Co., Ltd., solid content 100%)
[0531] [6] Photopolymerization initiator (E-1): a compound represented by the following formula: produced by the method described in JP-A-2011-132215 (solid content: 100%).
[0532]
[0533] [7] Photopolymerization initiator (E-2): Irgacure OXE01 (manufactured by BASF, solid content 100%)
[0534] [8] Antioxidant (F-1): Sumilizer-GP (phosphorus / phenol composite antioxidant, manufactured by Sumitomo Chemical Co., Ltd., solid content 100%)
[0535] [9] Solvent (G-1): PGMEA (propylene glycol monomethyl ether acetate)
[0536]
[10] Solvent (G-2): Cyclohexyl acetate
[0537]
[11] Leveling agent (H-1): F-554 (fluorine-based leveling agent, manufactured by DIC Corporation, solid content 100%).
Claims
1. A curable resin composition comprising quantum dots (A), a compound (B-1) having a first functional group and a second functional group, a compound (B-3) other than the compound (B-1), a resin (C), a photopolymerizable compound (D) and a photopolymerization initiator (E), The first functional group is a carboxyl group, the second functional group is a carboxyl group or a thiol group, The compound (B-3) is at least one selected from an organic acid, an organic amine compound and a thiol compound, The mass ratio of the resin (C) to the photopolymerizable compound (D) is 1.5 or more in terms of solid content ratio.
2. The curable resin composition according to claim 1, wherein The molecular weight of the compound (B-1) is 3,000 or less.
3. The curable resin composition according to claim 1 or 2, wherein The present invention further includes a compound (B-2) which is different from the compound (B-1), includes a polyalkylene glycol structure and has a polar group at a molecular terminal.
4. The curable resin composition according to claim 3, wherein The content of the compound (B-2) is 1 to 50 in mass ratio relative to the content of the compound (B-1).
5. The curable resin composition according to claim 1 or 2, wherein The resin (C) is a polyalkylene glycol compound.
6. The curable resin composition according to claim 1 or 2, wherein The content of the photopolymerizable compound (D) is 13% by mass or more based on the total amount of solid content of the curable resin composition.
7. The curable resin composition according to claim 1 or 2, wherein The photopolymerizable compound (D) contains 50% by mass or more of a photopolymerizable compound having three or more ethylenically unsaturated bonds in a molecule and having no carboxyl group.
8. The curable resin composition according to claim 1 or 2, wherein The photopolymerization initiator (E) includes an oxime compound having a first molecular structure represented by the following formula (1), In formula (1), R 1 Represents R 11 , OR 11 , COR 11 , SR 11 ,CONR 12 R 13 or CN, R 11 , R 12 and R 13 each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an aralkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms, R 11 , R 12 or R 13 The hydrogen atoms of the group represented by are not replaced or are replaced by OR 21 , COR 21 , SR 21 NR 22 Ra 23 ,CONR 22 R 23 , -NR 22 -OR 23 , -N(COR 22 )-OCOR 23 、-C(=N-OR 21 )-R 22 、-C(=N-OCOR 21 )-R 22 , CN, halogen atoms, or COOR 21 replace, R 21 , R 22 and R 23 each independently represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an aralkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms, R 21 , R 22 or R 23 The hydrogen atoms of the groups represented by are not substituted or are substituted by CN, halogen atoms, hydroxyl groups, or carboxyl groups, R 11 , R 12 , R 13 , R 21 , R 22 or R 23 When the group represented by has an alkylene moiety, the alkylene moiety is not interrupted or is composed of -O-, -S-, -COO-, -OCO-, -NR 24 -, -NR 24 CO-、-NR 24 COO-、-OCONR 24 -, -SCO-, -COS-, -OCS- or -CSO- interrupted 1 to 5 times, R 24 represents a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an aralkyl group having 7 to 30 carbon atoms, or a heterocyclic group having 2 to 20 carbon atoms, R 11 , R 12 , R 13 , R 21 , R 22 or R 23 When the group represented by has an alkyl portion, the alkyl portion is branched or cyclic. 12 With R 13 and R 22 With R 23 respectively form a ring together or not form a ring, * represents a bonding site to another molecular structure other than the first molecular structure of the oxime compound, that is, the second molecular structure. 9 . A cured film formed from the curable resin composition according to claim 1 . 10 . A display device comprising the cured film according to claim 9 .
